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Abstract

Curcumin Inhibits the IKK:NF-kB Pathway in Neural Fear Circuits
by
Miguel A Briones

Adviser: Professor Glenn E. Schafe

The study of how the brain acquires fearful memories has attracted considerable
experimental attention, due in part to the promise of discovering novel therapeutic approaches
for psychiatric disorders that are characterized by unusually strong and persistent traumatic
memories. In recent years, extensive research has focused on studying the neural and molecular
mechanisms by which fear memories are acquired, stored, and retrieved in the brain. Once
acquired, fear memories may be attenuated using one of 2 procedures: 1) fear extinction, which
involves repeated presentation of the fear-arousing stimulus in the absence of an aversive
consequence, or 2) interference with the reconsolidation process. The discovery of novel
pharmacological approaches that modulate the consolidation, reconsolidation, and extinction of
fear memories may thus have considerable clinical significance.
Our lab has recently shown that a diet enriched with curcumin; a polyphenol compound
found in the rhizome of the turmeric plant (Curcuma longa), impairs the consolidation and
reconsolidation of an auditory Pavlovian fear memory. However, there remained a question as to
whether, 1) curcumin had any effect on the extinction of an auditory Pavlovian fear memory, and
iv

2) whether curcumin’s effects were localized within the brain. Studies have shown extensive
evidence for curcumin as an inflammatory inhibitor, specifically of the IKK:NF-kB
inflammatory signaling pathway. Further, the IKK:NF-kB inflammatory signaling pathway has
been implicated in processes of learning and memory. Therefore, the aim of this dissertation was
to systematically elucidate the mechanisms by which curcumin affects the consolidation,
reconsolidation, and extinction of an auditory Pavlovian fear memory, focusing on whether the
IKK:NF-kB inflammatory signaling pathway is involved.
In Chapter 2, we find that direct infusions of curcumin into the lateral amygdala (LA), the
primary site of acquisition and storage of fear memories in the brain, impairs training-related
upregulation of the IKK-a enzyme, and impairs the consolidation of an auditory Pavlovian fear
memory. In Chapter 3, we find that direct infusions of curcumin into the LA impairs retrievalrelated upregulation of the IKK-a enzyme and impairs the reconsolidation of an auditory
Pavlovian fear memory. Surprisingly, in Chapter 4, we observe that a dietary source of curcumin
facilitates the extinction of an auditory Pavlovian fear memory. Further, direct infusions of
curcumin into the infralimbic cortex (IL), immediately after extinction training, facilitated the
retention of an extinction memory. Interestingly, a dietary source of curcumin impairs the
extinction-related upregulation of the IKK-a enzyme within the IL. Collectively, we provide
evidence that curcumin impairs the consolidation and reconsolidation, while facilitating the
extinction, of an auditory Pavlovian fear memory. Further, all three behavioral effects are
correlated with the downregulation of the IKK: NF-kB inflammatory signaling pathway.
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Chapter 1: General Introduction
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Advances in modern biology have allowed scientists to explore the neural underpinnings
of psychiatric disorders. In recent years, the field of neuroscience has investigated the brain
mechanisms that underlie disorders characterized by traumatic memories using an animal model
of traumatic memory formation, called Pavlovian fear conditioning (Fanselow, 1980; LeDoux,
2000; LeDoux, Sakaguchi, & Reis, 1984).
Newly acquired Pavlovian fear memories are thought to be inherently unstable, acquiring
stability over time as they are ‘consolidated’ into long-term representations in the brain. Later
retrieval of the Pavlovian fear memory is known to trigger a new phase of instability for a brief
window of time during which the memory may be updated (e.g. strengthened or weakened) prior
to being re-stabilized in a process known as ‘reconsolidation’ (Nader, Schafe, & LeDoux, 2000).
Further, consolidated Pavlovian fear memories may be inhibited through another process known
as extinction, in which the conditioned stimulus is presented repeatedly in order to establish a
new memory that prevents the fear response (Myers & Davis, 2006).
The study of the neural and molecular mechanisms underlying the consolidation,
reconsolidation, and extinction of Pavlovian fear memories has attracted considerable
experimental attention, due in part by the promise of discovering novel pharmacological
approaches that impair the reoccurrence of a fear memory. This, in turn, may be useful in the
treatment of trauma- and stressor-related disorders, such as Acute Stress Disorder (ASD) and
Post-Traumatic Stress Disorder (PTSD), which are characterized by unusually strong and
persistent traumatic memories (Daskalakis, Yehuda, & Diamond, 2013; Mahan & Ressler, 2012;
Milad & Quirk, 2012). While this research has steadily progressed over the years, there are few
pharmacological compounds readily available for use in a clinical setting (Berger et al., 2009).
Antidepressant medication, including selective serotonin-reuptake inhibitors (SSRIs), remains
2

the only approved pharmacological treatment for PTSD. While treatment with SSRIs have
shown some promise, there are side effects associated with SSRI-treatment, and as many as 50%
of patients fail to respond to the treatment all together (Berger et al., 2009). Therefore,
researchers have begun to investigate alternative pharmacological compounds that could be used
either alone or in conjunction with existing treatments.
In recent years, interest has grown in so-called ‘nutraceuticals,’ naturally occurring
compounds that have medicinal applications. One of the best-described nutraceuticals is the
yellow pigment polyphenol compound curcumin, which is normally found in the Indian spice
turmeric (Curcuma longa). Curcumin has been extensively studied for its anti-inflammatory,
chemopreventive, and neuroprotective properties, and has been shown to target the IKK:NF-kB
inflammatory signaling pathway, which is involved in cellular responses to stress and bacterial
antigens, as well as synaptic plasticity and memory (Gupta, Patchva, & Aggarwal, 2013; Lim,
2016; Prasad, Gupta, Tyagi, & Aggarwal, 2014). Most strikingly, there is mounting evidence that
curcumin is effective in reducing depressive-like symptoms in animal models (Bhutani, Bishnoi,
& Kulkarni, 2009; Jiang et al., 2013; Kulkarni, Dhir, & Akula, 2009; Pankti, Roy, Patel, &
Gohil, 2014; Zhang et al., 2012). Yet, the effects of curcumin in relation to trauma- and stressorrelated disorders remain poorly understood, and there has yet to be a formal study on the effects
of curcumin on the formation and modulation of Pavlovian fear memories. Therefore, the overall
goal of this dissertation is to explore the effects of curcumin on the consolidation,
reconsolidation, and extinction of Pavlovian fear memories. In this introductory chapter, I will
first review our current understanding of trauma- and stressor-related disorders, with a particular
focus on PTSD. I will then review the importance of the amygdala in the formation of a
Pavlovian fear memory. Then, I will discuss the reconsolidation and extinction process in
3

relation to Pavlovian fear memories and explore their clinical significance. I will then review the
IKK:NF-kB inflammatory signaling pathway and discuss its relation to Pavlovian fear memory
formation. Finally, I will discuss the pharmacological effects of curcumin, alongside evidence
that dietary curcumin impairs the consolidation and reconsolidation of a Pavlovian fear memory.
Trauma – and Stressor-Related Disorders
The DSM-V categorizes trauma- and stressor-related disorders as disorders in which
exposure to a traumatic event is a fundamental criterion for the diagnosis (American Psychiatric
Association, 2013). The DSM-V lists five trauma- and stressor-related disorders, which include
Reactive Attachment Disorder, Disinhibited Social Engagement Disorder, Adjustment Disorder,
Acute Stress Disorder (ASD), and Post-Traumatic Stress Disorder (PTSD). It may be that some
individuals express trauma- and stressor- related symptomology but do not meet full criteria to
be diagnosed within a category mentioned above. The clinician may choose to apply an Other
Specified Trauma- and Stressor- Related Disorder or Unspecified Trauma- and Stressor-Related
Disorder label, depending on whether the clinician has enough information to explain why an
individual should be classified with a trauma- and stressor-related disorder but not within the five
distinct categories (American Psychiatric Association, 2013).
Researchers argue that the grouping of these disorders under a trauma and stress category
will enable clinicians to differentiate between normal, stressful reactions to traumatic events and
more severe and chronic psychopathology (Friedman, Resick, Bryant, & Brewin, 2011). In some
cases, individuals exposed to a traumatic event exhibit a phenotype that is characterized as
anxiety- or fear-based. Other individuals, however, may exhibit anhedonic or dysphoric
symptoms, which are expressed externally as aggressive behavior or dissociation (Friedman et
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al., 2011). It is evident, however, that trauma- and stressor-related symptomology exists on a
spectrum.
Reactive Attachment, Disinhibited Social Engagement, and Adjustment Disorder
Reactive attachment disorder and disinhibited social engagement disorder develop when
a child experiences a stressful environment that is characterized by social neglect or deprivation,
repeated changes in caregivers, and/or diminished ability to form selective attachments to care
givers (American Psychiatric Association, 2013). Reactive attachment disorder manifests as a
pattern of emotionally withdrawn behavior and persistent social and emotional disturbance in the
child. In contrast, disinhibited social engagement disorder is exhibited as a pattern of behavior in
which a child actively approaches and engages with unfamiliar adults and displays diminished
need for reassurance from an adult caregiver (American Psychiatric Association, 2013).
Although distinct in behavioral outcomes, both disorders are rooted in traumatic, stressful
experiences during childhood.
Adjustment disorders are defined by a progression of emotional and behavioral
symptoms around three months after the onset of a known stressor or stressors. The symptoms
are clinically validated by either marked distress that deviates extremely from the gravity of the
stressor, significant impairment in important areas of daily functioning, or a combination of both
(American Psychiatric Association, 2013).
Intrusion of the Traumatic Event: Acute Stress and Post-Traumatic Stress Disorder
PTSD and ASD are characterized by an experience of a traumatic event that is life
threatening, involves serious injury, or sexual violence (American Psychiatric Association,
2013). This traumatic event could be experienced directly, witnessed in person, or experienced
indirectly by learning that it happened to a loved one. Unlike the three aforementioned
5

categories, ASD and PTSD can be distinguished as disorders in which intrusion of the traumatic
event is a core component of the disorder (Yehuda, 2002; Yehuda & LeDoux, 2007). These
intrusion symptoms can manifest themselves as recurrent, involuntary memories of the traumatic
event, recurrent dreams in which the content is related to the traumatic event, dissociative
reactions in which the individual experiences the recurring traumatic event (flashbacks), and
intense, marked physiological and psychological distress to internal and external cues that
resemble an aspect of the traumatic event(s) (Yehuda, 2002; American Psychiatric Association,
2013).
Individuals also display avoidance symptoms, which involve restricting one’s thoughts
and distracting oneself from reminders of the traumatic event. There is also a marked alteration
of cognitions and mood that are associated with the traumatic event, such as persistent negative
beliefs of oneself, depersonalization, derealization, or a persistent negative emotional state.
Physiological changes also accompany ASD and PTSD, such as insomnia, irritability, impaired
concentration, hypervigilance, and increased startle responses (Yehuda, 2002; American
Psychiatric Association, 2013).
It is important to note that ASD and PTSD are differentiated by the time course of
symptomology after the traumatic event(s). ASD is typically diagnosed 3 days to 1 month after
the traumatic event. If symptomology persists for longer than a month, and the individual meets
all criteria for PTSD, then the diagnosis switches from ASD to PTSD (American Psychiatric
Association, 2013).
Although trauma- and stressor-related disorders are complex in their symptomology, it
may be argued that traumatic memories are a linchpin symptom (Yehuda & LeDoux, 2007).
Indeed, much of the symptomology related to ASD and PTSD are a result of a traumatic
6

experience that is intrusively replayed as a memory. Therefore, scientist have focused
extensively on pre-clinical neurobiological investigations of intrusive traumatic memories
(Pitman et al., 2012). Researchers believe that the formation and re-experiencing of the traumatic
event mimics a similar associative learning processes known as Pavlovian fear conditioning.
The Amygdala and Pavlovian Fear Memories
Research focused on studying the neural mechanisms of fear memory acquisition,
formation, and retrieval has used an animal model of fear learning known as Pavlovian fear
conditioning (Fanselow, 1980; LeDoux, 2000; Maren, 2001; Davis, 1992). Pavlovian fear
conditioning involves pairing an initially neutral stimulus (the conditioned stimulus; CS) with an
aversive unconditioned stimulus (US). After pairing the two stimuli together, the CS, when
presented alone, begins to elicit a behavioral fear response, referred to as a conditioned response
(CR) (Pavlov, 1927). If you were to translate this idea to PTSD symptomology, individuals
initially react to the traumatic event (US), which produces arousal and fear (UR). The individual
continues to show arousal (CR) when confronted with trauma-related cues (CS), long after the
trauma (Daskalakis et al., 2013; Yehuda & LeDoux, 2007).
Multiple sensory stimuli (such as visual, olfactory, and auditory) may be used as a CS,
but auditory fear conditioning has been studied most extensively at the neural, cellular and
molecular levels (Johansen, Cain, Ostroff, & LeDoux, 2011; Maren, 2001; Sigurdsson, Doyère,
Cain, & LeDoux, 2007; Tovote, Fadok, & Lüthi, 2015). The paradigm is simple; the animal, in
this case a rodent, is habituated to the conditioning box on day 1. On day 2, the rodent is brought
back to the conditioning box and is given a number of tone-shock pairings. The tone is the CS,
while the footshock is the US. On day 3, the rodent is placed in a novel context, and is exposed
to a number of CS presentations, which elicits freezing behavior (CR). It is important to note that
7

the acquisition of learned fear results from the association of the tone with the footshock. When
the tone and footshock are not paired, the association is not made (Rogan, Stäubli, & LeDoux,
1997).
Particularly important is the discovery that the amygdala plays a central role in Pavlovian
fear conditioning (Amano, Duvarci, Popa, & Paré, 2011; Fanselow & LeDoux, 1999; LaBar,
Gatenby, Gore, LeDoux, & Phelps, 1998; J. LeDoux, Cicchetti, Xagoraris, & Romanski, 1990;
Rogan et al., 1997; Schafe, Nader, Blair, & LeDoux, 2001; Davis & Whalen, 2000). The
amygdala is an almond shaped structure, located deep within the temporal lobe, which receives
sensory information from almost all modalities, including olfactory, somatosensory, visceral,
auditory and visual, via projections from the thalamus and cortex (Sah, Faber, Armentia, &
Power, 2003). The prefrontal cortex is also a major source of cortical projections to the
amygdala, and there are strong reciprocal connections between the hippocampus,
parahippocampal cortex, entorhinal cortex and the amygdala (Sah et al., 2003).
Studies have shown that the key circuits involved in auditory fear conditioning involve
sensory areas that process the CS and the US, regions in the amygdala that process the
acquisition and consolidation of the fear memory, and regions in the amygdala that relay
information to other brain areas to elicit a conditioned response (Fanselow, 1980; J. E. LeDoux,
2000; JE LeDoux, Sakaguchi, & Reis, 1984). During fear acquisition, the sensory information
about the tone and the shock converge onto neurons in the lateral nucleus of the amygdala (LA),
where synaptic plasticity and the activation of molecular signaling pathways produce an
enhanced response of these neurons to the CS (Blair, Schafe, Bauer, Rodrigues, & LeDoux,
2001; Maren & Fanselow, 1995; Schafe et al., 2001; Weisskopf, Bauer, & LeDoux, 1999).
During the expression of the fear memory, the LA activates the central nucleus of the amygdala
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(CE), either directly or indirectly through projections to the basal and accessory nucleus of the
amygdala and the intercalated masses (ITC) (Likhtik, Pelletier, Popescu, & Paré, 2006; Sah et
al., 2003). The basal and accessory basal nucleus project to the CE directly and have a key role
in controlling output of processed information from the CE (Sah et al., 2003; Wilensky, Schafe,
Kristensen, & LeDoux, 2006). The ITC receive glutamatergic input from the basal lateral
nucleus of the amygdala (BLA) and sends GABAergic output to the CE (Kaoru et al., 2009). The
CE, in turn, projects to hypothalamic and brain stem areas that elicit defensive behaviors, such as
freezing, and autonomic and endocrine responses (Fanselow, 1980; Hitchcock & Davis, 1986;
LeDoux, 2000). The processing of threat is key in the circuitry of the amygdala, and there is
strong evidence implicating the LA as the site of fear memory consolidation and storage
(Amano, Duvarci, Popa, & Paré, 2011; Fanselow & LeDoux, 1999; LaBar, Gatenby, Gore,
LeDoux, & Phelps, 1998; JE LeDoux, Cicchetti, Xagoraris, & Romanski, 1990; Rogan et al.,
1997; Schafe, Nader, Blair, & LeDoux, 2001; Davis & Whalen, 2000).
Cellular and Molecular Mechanisms of Fear Memory Within the Lateral Amygdala
Studies have investigated the cellular mechanisms of fear memory consolidation, in
which temporary, labile short-term memories (STM) are transformed into long lasting long-term
memories (LTM) (Kandel, Dudai, & Mayford, 2014; McGaugh, 2000). A number of intracellular
mechanisms have been implicated in the fear memory consolidation process, including protein
kinase signaling pathways (Apergis-Schoute, Debiec, Doyère, LeDoux, & Schafe, 2005;
Rodrigues, Farb, Bauer, LeDoux, & Schafe, 2004; Schafe et al., 2000; Schafe, Nadel, Sullivan,
Harris, & LeDoux, 1999; Schafe & LeDoux, 2000), transcription factors (Alberini, 2009; Hall,
Thomas, & Everitt, 2001; Josselyn et al., 2001; Rattiner, Davis, French, & Ressler, 2004),
histone acetyltransferases (HAT) (Dias, Maddox, Klengel, & Ressler, 2015; Kwapis & Wood,
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2014; Maddox, Schafe, & Ressler, 2013; Maddox, Watts, & Schafe, 2013), mRNA and protein
synthesis (Lamprecht & LeDoux, 2004; Schafe et al., 1999; Schafe & LeDoux, 2000), and the
expression of immediate early genes and late response genes (Dias, Maddox, Klengel, & Ressler,
2015; Kwapis & Wood, 2014; Maddox, Schafe, & Ressler, 2013; Maddox, Watts, & Schafe,
2013).
THALAMIC
NEURON
TERMINAL

LATERAL
AMYGDALA
SPINE

P
P

CaMKII

PKA

P
P

MAPK

P
CREB

Figure 1.1 – Molecular Mechanisms of Fear Memory Formation at the Level of LA Neurons.

Studies have demonstrated that these molecular events follow a particular sequence
immediately after tone-shock pairing in the rodent (Johansen et al., 2011). The convergence of
the tone and shock information onto LA neurons leads to the opening of AMPA and NMDA
receptors, which in turn leads to increases in intracellular sodium and calcium concentrations
(McKernan & Shinnick-Gallagher, 1997; Weisskopf & LeDoux, 1999). The increase in calcium
concentrations phosphorylates various protein kinases (adds a phosphoryl-group to the protein
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kinase, denoted by P in Figure 1.1), such as protein kinase C (PKC), and calcium-calmodulin
dependent kinase II (CaMKII) (Rodrigues et al., 2004) (Figure 1.1).
At the same time, the release of epinephrine and norepinephrine by the footshock leads to
the activation of beta-adrenergic receptors (Bush, Caparosa, Gekker, & LeDoux, 2010), which in
turn activate adenylate cyclase (AC). AC then drives the production of cyclic AMP, which
phosphorylates protein kinase A (PKA). Activation of kinases also activates phosphoinositide3kinase (PI3-K), which phosphorylates mitogen activated protein kinase (MAPK), which
phosphorylates cyclic AMP response element binding protein (CREB) inside the nucleus
(Kandel, 2012).

Protein
Synthesis

P
CREB

P
P300

mRNA

CBP

P

Figure 1.2 – The Nucleus of the Lateral Amygdala Neuron During the Consolidation Process.
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The phosphorylation of CREB initiates an interaction between CREB and neuronal DNA
(Hall et al., 2001). DNA, however, is normally hidden by being wrapped around histone proteins,
forming a dense chromatin complex (Jarome & Lubin, 2014). Histone acetyltransferases (HATs),
a family of epigenetic enzymes, are responsible for acetylating histone proteins (adding an acetyl
group to the histone protein, denoted by A in Figure 1.2), which changes their conformation to
allow the DNA to be exposed for transcription (Levenson & Sweatt, 2005; Roth, Jnu, & Allis,
2001). Recent evidence has implicated the p300/CBP HAT in the consolidation of a Pavlovian
fear memory (Maddox et al., 2013). As protein kinases phosphorylate CREB, HATs, such as
p300/CBP, acetylate chromatin to expose the neuron’s DNA (Zovkic & Sweatt, 2013). This
allows CREB to bind to the cyclic AMP response element (CRE) promoter region of the DNA,
which leads to the expression of various immediate early genes (IEGs) such as Arc and EGR-1
(Maddox & Schafe, 2011; Maddox et al., 2011; Ploski et al., 2008). This process also leads to
RNA synthesis, and subsequent protein synthesis (Rumpel, LeDoux, Zador, & Malinow, 2005)
(Figure 1.2). The end result is the formation of new AMPA receptors at the LA synapse, which
leads to the strengthening of the tone-shock association within the LA synapse so that, when the
CS tone is played alone, LA neurons are more likely to strongly respond and lead to a behavioral
expression of fear.
Turning Off Learned Fears: Erasing Fear Memories through Reconsolidation Interference
It was once believed that a consolidated memory was stored in a fixed state for as long as
it persisted (Squire, 1986). However, we now know that the retrieval of a consolidated Pavlovian
fear memory triggers a new phase of instability for a brief window of time during which the
memory may be updated (e.g. strengthened or weakened) prior to being re-stabilized (Debiec,
LeDoux, & Nader, 2002; Nader et al., 2000). This process is known as fear memory
12

reconsolidation and has been hypothesized to serve an important physiological role for updating
memories (Wang & Morris, 2010). Specifically, this strengthening or weakening of a fear
memory generally holds true for memories in which there is a mismatch between what the
memory predicts and what actually takes place during retrieval (Wang & Morris, 2010). As a
consequence, these memories can be enhanced with updated information, or weakened and thus
forgotten if they no longer serve a physiological purpose (Alberini & LeDoux, 2013). This
makes sense in light of survival; we want to remember the important associations and forget the
ones that do not benefit us.
Fear memory reconsolidation was demonstrated in a set of experiments by Nader, Schafe
& LeDoux (2000), in which infusion of anisomycin, a protein synthesis inhibitor, directly into
the lateral amygdala after the recall of a Pavlovian fear memory impaired later (~24 hours) recall
of the same fear memory. This effect was shown to be dependent on the recall of the fear
memory; if anisomycin was infused without recall of the fear memory, later recall (~24 hours) of
the same fear memory remained intact. The experiments provided evidence that 1) the Pavlovian
fear memory is unstable when recalled, and 2) that reconsolidation is dependent on protein
synthesis in the lateral amygdala.
These initial experiments were followed by a number of studies demonstrating a complex
picture of molecular events needed for reconsolidation to occur (Alberini & LeDoux, 2013;
Dębiec & Ledoux, 2004; Dudai, 2006; Duvarci, Nader, & LeDoux, 2005; Suzuki et al., 2004;
Tronson & Taylor, 2007). During recall of the fear memory, there is a destabilization process,
regarded as deconsolidation, which requires protein degradation and the activation of NMDA
receptors (Fanselow, 1980; J. E. LeDoux, 2000; S Maren, 2001; Davis, 1992). In order for the
memory to be reconsolidated, a molecular process similar to consolidation is initiated. L-type
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voltage gated calcium channels (L-VGCCs) are then engaged to promote the induction of
calcium, leading to the activation of many of the same kinases activated during consolidation,
such as MAPK, ERK, and PKA (Dębiec & Ledoux, 2004; Duvarci, Nader, & LeDoux, 2008;
Hall et al., 2001; Maddox & Schafe, 2011; Sara, 2000; Tronson & Taylor, 2007). Like the
consolidation process, specific transcription proteins are phosphorylated, such as CREB and
HATs, which leads to transcription and translation. This leads to the synthesis of protein, and
thus allows the memory to become re-stabilized.
Reconsolidation has been heavily investigated due to the notion that interfering with the
reconsolidation process weakens the original fear memory (Alberini & LeDoux, 2013). For
example, disrupting reconsolidation using pharmacological inhibition impairs further retrieval of
the fear memory, regardless of context or re-exposure to the aversive stimulus (Dudai, 2006;
Maren, 2013; Merlo, Milton, Goozée, Theobald, & Everitt, 2014; Nader, 2003; Nader &
Einarsson, 2010; Nader & Hardt, 2009; Rose & Rankin, 2006; Sara, 2000). Therefore,
interference of the reconsolidation process offers a potential route by which a recurring traumatic
memory may be disrupted.
Turning Off Learned Fears: The Inhibition of Fear Memories through Extinction
The modulation of Pavlovian fear memories may also be achieved through the process of
extinction, in which a CR is diminished through repeated presentations of an unreinforced CS
(Milad & Quirk, 2012; Milad, Rauch, Pitman, & Quirk, 2006; Myers & Davis, 2006). In the case
of fear, extinction involves the reduction of a conditioned fear response with the repeated
presentation of a conditioned fear stimulus (Maren & Quirk, 2004; Milad & Quirk, 2002;
Morgan, Romanski, & LeDoux, 1993). For rodent auditory Pavlovian fear conditioning, repeated
presentations of the tone CS over time reduces the CR of freezing. It is important to note that
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fear memory extinction does not erase the initial learned association between the CS (tone) and
the US (shock), but rather creates a new learned association that inhibits the expression of the
CR (Monfils, Cowansage, Klann, & LeDoux, 2009; Quirk, 2002; Suzuki et al., 2004).
Evidence that the initial learned association is still present comes from the phenomena of
spontaneous recovery, reinstatement, and fear renewal. Twenty-four hours after extinction
training, a rodent will express spontaneous recovery, in which the first few CS presentations in a
new testing session induces a heighted fear response. If you place a rodent in a completely new
context (Context C) one week after extinction training, and deliver one US presentation
(footshock), the fear memory will become reinstated and the rodent will display a heightened
fear response twenty-four hours after the reinstatement trial. Finally, if you place the rodent in a
completely new context (in this case, Context D) one week after extinction training, and present
the CS, the rodent will display a high fear response as if the original fear memory was renewed
(Myers & Davis, 2006; Quirk, Garcia, & González-Lima, 2006; Rescorla, 2004). Therefore,
facilitating or enhancing the fear extinction process, in a manner that is less susceptible to
reinstatement and renewal, can have important clinical significance.
In order to understand how fear extinction memories can be facilitated, researchers have
extensively studied the brain regions involved in the extinction of a fear memory. Animal studies
have shown that lesions of the rodent equivalent of the ventromedial prefrontal cortex, the
infralimbic cortex (IL), has no effect on fear acquisition but impairs the consolidation of fear
extinction (Milad & Quirk, 2002). Further, Quick and colleagues showed that lesions of the IL
do not impair within-session extinction but impairs the retention of the extinction memory 24
hours later (Milad & Quirk, 2002). Therefore, the process of extinction can be broken down into
separate events: acquisition, consolidation, and retrieval.
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Much like the consolidation and reconsolidation of a fear memory, the consolidation of
an extinction memory requires a cascade of molecular events, including the activation of NMDA
receptors (Burgos-Robles, Vidal-Gonzalez, Santini, & Quirk, 2007; Quirk & Mueller, 2008),
chromatin modifying enzymes (Stafford & Lattal, 2011; Stafford, Raybuck, Ryabinin, & Lattal,
2012; Lattal & Wood, 2013; Wei et al., 2012), and protein synthesis (Santini, Ge, Ren, de Ortiz,
& Quirk, 2004) in the IL. Further, pharmacologically inhibiting many of these molecular events
in the IL impairs the recall of an extinction memory (Herry & Mons, 2004; Itzhak, Anderson,
Kelley, & Petkov, 2012; Laurent & Westbrook, 2009; Merlo et al., 2014). Interestingly,
pharmacologically or optogenetically enhancing these molecular pathways in the IL facilitates
the extinction of a fear memory (Alaghband et al., 2017; Do-Monte, Manzano-Nieves, QuiñonesLaracuente, Ramos-Medina, & Quirk, 2015; Klavir, Prigge, Sarel, Paz, & Yizhar, 2017; Wei et
al., 2012; Whittle & Singewald, 2014).
The Wider Fear Circuit
It would be overly simplistic to only implicate the LA in the consolidation and
reconsolidation of a Pavlovian fear memory, and the IL in the extinction of a Pavlovian fear
memory. Although both areas have received considerable attention from researchers over the
past few decades, these fear memory processes involve a vast network of brain areas (Janak &
Tye, 2015). Fear conditioning is known to involve thalamic and cortical areas (Cambiaghi,
Grosso, Renna, & Sacchetti, 2016; Penzo et al., 2015), along with the lateral, central, basal, and
medial amygdala (Janak & Tye, 2015). In the case of contextual fear memory, the hippocampus
is highly involved, as hippocampal lesions impair the recall of a contextual fear memory (Kim &
Fanselow, 1992; Kim, Rison, & Fanselow, 1993; Phillips & LeDoux, 1992). Interestingly,
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consolidation of a remote auditory fear memory (in this case ~24 days) appears to involve
plasticity in cortical areas (Cambiaghi, Grosso, Renna, & Sacchetti, 2016; Penzo et al., 2015).
The prelimbic cortex (PL) has been implicated in the acquisition of a Pavlovian fear
memory (Burgos-Robles, Vidal-Gonzalez, & Quirk, 2009; Corcoran & Quirk, 2007; Laurent &
Westbrook, 2009), with studies showing that neural activity increases in the PL during
acquisition (Sierra-Mercado, Padilla-Coreano, & Quirk, 2010). The PL is located dorsally to the
IL, and studies have demonstrated that as a rodent undergoes extinction, there is decreased
activity in the PL, while activity in the IL increases. A lesion of the PL impairs the acquisition of
a fear memory, but not the consolidation, and vice versa for lesions of the IL (Sierra-Mercado,
Padilla-Coreano, & Quirk, 2010). More importantly, the extinction of a fear memory involves
the activation of inhibitory interneurons within the amygdala called the intercalated cell masses
(ITC), which are GABAergic neurons situated between the lateral and central amygdala. Studies
show that as a fear memory undergoes extinction, the IL drives the basal amygdala, which in
turns activates the ITC (Likhtik et al., 2006; Likhtik, Popa, Apergis-Schoute, Fidacaro, & Paré,
2008). The activation of the ITC in turn inhibits the activation the central amygdala, causing a
dampening of the fear response. Although it would be interesting to explore the molecular
underpinnings of all these substrates in relation to a Pavlovian fear memory, it is beyond the
scope of this dissertation. However, the LA and IL prove to be ideal brain areas to study, as both
have been studied extensively in relation to the consolidation, reconsolidation, and extinction of
a Pavlovian fear memory.
A Missing Link – Translating Evidence to PTSD
Understanding the mechanisms of traumatic memory modulation has been a major focus
of ASD and PTSD treatment (Bowers & Ressler, 2015; Daskalakis et al., 2013; Deslauriers,
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Toth, Der-Avakian, & Risbrough, 2018). Yet, despite having learned a considerable amount
about where and how fear memories are formed and modulated in the brain, pharmacological
treatment for ASD and PTSD remains elusive (Thomaes et al., 2014; Yehuda, 2002; Yehuda &
LeDoux, 2007). The traumatic event experienced by an individual who develops ASD or PTSD
results in a memory, presumably, that is so intense and distressing that it develops into an
intrusive everyday experience that is debilitating (Auxéméry, 2018; Yehuda, 2002).
Extinction-based exposure therapy is often used in the clinical setting to reduce traumaand stressor-related symptomology (Milad & Quirk, 2012; Morrison & Ressler, 2014; Rauch &
Phelps, 2006). Studies have shown that PTSD patients show response rates of about 50 % at
post-treatment and 54 % at follow-up (Bowers & Ressler, 2015; Maren, 2011; Rauch et al.,
2006). Further, patients diagnosed with PTSD have been shown to have reduced activation of the
ventral medial pre-frontal cortex (vmPFC) (Liberzon & Zapada, 2007; Pitman et al., 2012), an
area that is critical for the retrieval of an extinction memory.
Because ASD and PTSD often comorbid with other mental illnesses, such as substance
dependence or depression, the common approach to treatment has been to target comorbid
symptomology (Bowers & Ressler, 2015; Sherin & Nemeroff, 2011; Thomaes et al., 2014).
Antidepressants, such as selective serotonin reuptake inhibitors, have been a common
pharmacological treatment for PTSD (Sofuoglu, Rosenheck, & Petrakis, 2013). Additionally,
drugs like benzodiazepines and anti-seizure medications have been used because disorders like
PTSD, generalized anxiety disorder, and alcohol dependence are associated with low levels of
GABA (Sofuoglu et al., 2013). Although many of the pharmacological treatments relieve
symptoms, they do not work in all patients (Berger et al., 2009). It is also possible that what the
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pharmacological agents are targeting may have nothing to do with what is causing the disorder
(Auxéméry, 2018; Horn, Charney, & Feder, 2016).
Interfering with the reconsolidation process could be a potential therapeutic approach and
disrupted reconsolidation has been demonstrated in human subjects (LaBar et al., 1998; Schiller
et al., 2010; Schiller & Phelps, 2011; Steinfurth et al., 2014). Many of the successful experiments
in animal models, however, have used compounds that are harmful to the human body. Further,
many studies have introduced these compounds directly into the brain through cannulations, a
procedure that is not ideal to a patient (Alberini & LeDoux, 2013; Tronson & Taylor, 2007).
Propranolol, a beta-adrenergic antagonist, has been found to impair the acquisition and
reconsolidation of a rodent Pavlovian fear memory (Alberini & LeDoux, 2013; Dębiec &
Ledoux, 2004; Dudai, 2006; Duvarci, Nader, & LeDoux, 2005; Suzuki et al., 2004; Tronson &
Taylor, 2007). Propranolol treatment in human clinical trials, however, has not been as effective
as rodent studies suggest (McGhee et al., 2009; Muravieva & Alberini, 2010; Nugent et al.,
2010).
Therefore, it has been of clinical importance to find a compound that can be used with
greater efficacy in targeting symptomology, and that is safe to use in clinical populations.
Cellular mechanisms involved in the formation and modulation of Pavlovian fear memories
could be novel pharmacological targets.
The Fear Circuit Revisited: IKK:NF-kB and Pavlovian Fear Memories
Recently, there has been evidence that the IKK:NF-kB inflammatory signaling pathway
is implicated in the consolidation, reconsolidation, and extinction of Pavlovian fear memories
(Boccia et al., 2007; Lubin & Sweatt, 2007; Si et al., 2012; Yang et al., 2012). Historically, the
IKK:NF-kB inflammatory signaling pathway has been heavily studied in relation to
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inflammatory diseases and cancer (Baeuerle & Baltimore, 1996; Chen & Greene, 2004). Studies
have shown that inhibiting the activation of the IKK:NF-kB inflammatory signaling pathway invitro in cancer and tumor cells leads to cancer cell apoptosis (Ben-Neriah & Karin, 2011; Karin,
Yamamoto, & Wang, 2004). Further, recent evidence points to the involvement of the IKK: NFkB signaling pathway in a host of other biological functions, including memory formation
(Albensi & Mattson, 2000; Hayden & Ghosh, 2011; Małek, Borowicz, Jargiełło, & Czuczwar,
2010; O’Neill & Kaltschmidt, 1997; Salles, Romano, & Freudenthal, 2014). The IKK:NF-kB
signaling pathway is activated by most inflammatory cytokines, environmental pollutants,
viruses, and physical and psychological stress (Ben-Neriah & Karin, 2011; Michael Karin,
Yamamoto, & Wang, 2004).
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Figure 1.3 – The IKK:NFkB Inflammatory Signaling Pathway.
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The activation of the IKK:NF-kB pathway comprises the sequential activation of NF-kB
induced kinase (NIK), which then subsequently activates IkB kinase (IKK) that degrades IkB
and phosphorylates NF-kB (Lawrence, 2009; Oeckinghaus & Ghosh, 2009). NF-kB is then able
to translocate into the nucleus, where it binds to specific kB DNA sequences in the enhancer
regions of a variety of kB responsive genes (Figure 1.3). The pathway consists of three main
molecular families, NF-kB, IkB, and IKK. NF-kB consists of five proteins: p50, p65 (RelA),
p52, RelB, and c-Rel (Hayden & Ghosh, 2011; Oeckinghaus & Ghosh, 2009). IkB exists in three
forms; IkB-a, IkB-b, and IkB-e. IkB kinase (IKK) consists of three different parts. IKK-a and
IKK-b are catalytically active, while IKK-g is the regulatory subunit.
At that molecular level, almost all cells contain genes that have specific sites for NF-kB
in the promoter/enhancer region (Sen & Smale, 2010; Smale, 2011). Once the NF-kB is freed, it
translocates into the nucleus and binds to various target genes that code for regulatory proteins,
cytokines (such as interleukin 1-β and tumor necrosis factor α), NF-kB regulatory proteins, and
apoptosis (Oeckinghaus & Ghosh, 2009).
To terminate the NF-kB response, there is a resynthesis of IkB proteins induced by
translocated NF-kB from DNA. The newly synthesized IkB alpha binds with NF-kB dimers,
which leads to the export of the IkB:NF-kB complex into the cytoplasm. The NF-kB pathway
should not be permanent, and a return to homeostasis is needed in order to prevent inflammation,
oncogenesis, and other autoimmune diseases (Ruland, 2011).
Interestingly, the IKK: NF-kB inflammatory pathway has been to be involved in
Pavlovian fear memories. Evidence has found that fear potentiated startle results in NF-kB
binding to DNA in the amygdala (Yeh, Lin, Lee, & Gean, 2002). Intra-amygdala infusions of an
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NF-kB inhibitor or a kB decoy were shown to significantly impair fear potentiated startle.
Further, Li et al. (2012) discovered that the IKK: NF-kB response is involved in the
reconsolidation of a Pavlovian fear memory. Infusion of an IKK inhibitor, sulfizidane impaired
the reconsolidation of a Pavlovian fear memory.
Lubin and Sweatt (2007) showed the involvement of the IKK: NF-kB signaling pathway
in the reconsolidation of a contextual fear memory within the hippocampus. Blocking the
activation of IKK in the hippocampus during retrieval led to impairments in the reconsolidation
of a Pavlovian contextual fear memory. Further, a recent study found that decreased levels of
IKK in the hippocampus were required for the extinction of a contextual fear memory (de la
Fuente, Freudenthal, & Romano, 2011). The authors found that if a rat is placed in the same
context in which it was conditioned for 5 min, IKK is significantly upregulated. Yet, if the rat
was left for > 30 minutes, levels of IKK began to decrease, leading the authors to conclude that
extinction of a contextual fear memory leads to a decrease in levels of IKK.
Therefore, the IKK-NF-kB pathway could be a potential pharmacological target for
modulating Pavlovian fear memories, and finding a safe, effective compound that targets this
pathway could prove to be clinically beneficial for treating intrusion symptomology associated
with trauma- and stressor-related disorders.
Curcumin
Curcumin, which was first isolated two centuries ago from the rhizomes of Curcuma
longa, has had a long history in Eastern traditional medicine (Gupta, devi Patchva, Koh, &
Aggarwal, 2012). Nicknamed the “Golden Spice,” curcumin has been used extensively for
various ailments. Scientific studies of curcumin have shown promise for its potential use in
various diseases (Gupta et al., 2012), with studies focusing on chronic inflammation in the gut,
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liver, and spinal cord (Wang & Morris, 2010), and suppression of various cancer and tumor cells
(Basnet & Skalko-Basnet, 2011; Gao & Tollefsbol, 2015; Hasima & Aggarwal, 2014). Recent
studies have shown that orally administered curcumin reduces symptoms of depression in rodent
models of major depressive disorder (MDD) (Fu et al., 2014; Hu et al., 2015; Kalani, Kamat,
Kalani, & Tyagi, 2015; Lim, 2016; Sánchez-Calvo et al., 2009; Wang et al., 2014). In human
clinical trials, curcumin has been shown to have effects on cancer, inflammation, pain, diabetes,
neurological disorders, and even depression (Lim, 2016; Lopresti, Maes, Maker, Hood, &
Drummond, 2014; Prasad et al., 2014; Sordillo & Helson, 2015; Yu, Pei, Zhang, Wen, & Yang,
2015). More importantly, the U.S. Food and Drug Administration labels curcumin as a safe
compound for human consumption.
Curcumin has been shown to target the IKK:NF-kB inflammatory pathway directly
(Singh & Aggarwal, 1995). Curcumin, at high doses, prevents the activation of the NF-kB
pathway when cells are treated with TNF-a, an NF-kB activator. Even at high doses of TNF-a,
curcumin was able to inhibit the activation of the IKK:NF-kB pathway, suggesting it to be a
potent inhibitor (Singh & Aggarwal, 1995). However, curcumin was not observed to inhibit NFkB from binding to DNA. Rather, curcumin was shown to inhibit the TNF-a dependent
phosphorylation and degradation of IkB alpha, which prevented the NF-kB subunit from
translocating into the nucleus (Jobin et al., 1999). Subsequently, Western blot analysis of both
the fractionated cytoplasm and nucleus showed that cells treated with curcumin had more NF-kB
in the cytoplasm than in the nucleus, suggesting that curcumin was inhibiting the translocation of
NF-kB into the nucleus, rather than NF-kB itself. Further research has shown that curcumin
affects IKK by suppressing its actions and leaving IkB levels elevated (Jobin et al., 1999). In
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other words, curcumin suppressed the phosphorylation of IKK, leaving it inactive, whereby IkB
could not be degraded. Therefore, curcumin has been shown to inhibit the IKK-NF:kB pathway
at the level of IKK. Given the previous discussion above, curcumin can potentially be an
effective modulator of Pavlovian fear memories.
The Story So Far: Dietary Curcumin Impairs Fear Memory Consolidation and Reconsolidation
Recent findings from our lab have shown that a dietary source of curcumin can
significantly impair the consolidation and reconsolidation of Pavlovian fear memories (Monsey
et al., 2015). Rats were either placed on a regular diet (e.g. standard rodent chow) or a diet that

Figure 1.4 – The Effects of Dietary Curcumin on Memory related IEGs and Fear Memory
Consolidation. (a) Schematic of the behavioral protocol. (b) Mean (±SEM) immunoreactivity for
Arc/Arg3.1 and Egr-1 proteins in the LA of Chow/Naive (n = 10), Curcumin/Naive (n = 10),
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Chow/Fear Conditioned (FC; n = 10), and Curcumin/FC (n = 10) groups 120 min after training.
Representative blots can be seen in the inset. Here, IEG protein levels have been normalized to
GAPDH levels for each sample. Each protein is expressed as a percentage of the Chow/Naive
group. *P<0.05, relative to the Chow/Naive group. (c) Mean (±SEM) post shock freezing in
Chow (n = 6) and Curcumin (n = 6) groups immediately after the conditioning trials. (d) Mean
(±SEM) STM assessed at 2 h after conditioning in each group. (e) Mean (±SEM) LTM assessed
24 h after conditioning in each group (Chow vs Curcumin; p<0.05) (from Monsey et al., 2015).
consisted of 1.5% curcumin for five days. On the sixth day, both groups were fear conditioned
and subsequently sacrificed two hours later for Western blot analysis. The focus was on two
memory-related immediately early genes (IEGs), Arc/Arg3.1 and Egr-1, which have each been
implicated in fear memory consolidation (Maddox & Schafe, 2011; Maddox et al., 2011; Ploski
et al., 2008).
Consistent with previous findings, both Arc/Arg3.1 and Egr-1 were significantly
upregulated in the LA in the group that was fed regular chow and fear conditioned. However, the
group that was fed curcumin and then fear conditioned did not exhibit increases in Arc/Arg3.1 or
Egr-1 in the LA after fear conditioning; that group exhibited levels of each IEG that were similar
to those of the naïve chow group and the naïve group fed curcumin (Figure 1.4b). This finding
indicated that a diet enriched with curcumin may prevent fear conditioning from regulating the
expression of memory-related genes in the LA.
In behavioral experiments, rats fed a diet enriched with curcumin exhibited impaired fear
memory consolidation. Rats that were exposed to a control diet or a curcumin-enriched diet were
fear conditioned and then tested for short-term memory (STM) two hours later and long-term
memory (LTM) twenty-four hours later. STM was intact for both groups, but LTM was
significantly impaired in the curcumin fed group compared to the regular diet controls (Figure
1.4d, e). This finding suggests that curcumin impaired the consolidation of the fear memory.
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Figure 1.5 – The Effects of Dietary Curcumin on Fear Memory Reconsolidation. (a) Schematic
of the behavioral protocol. (b) Mean (±SEM) post shock freezing in Chow (n = 6) and Curcumin
(n = 6) groups immediately after the conditioning trials. (c) Mean (±SEM) percent freezing in
each group during the reactivation trial. *P<0.05 relative to the pre-CS period. (d) Mean (±SEM)
PR-STM assessed 2 h after the reactivation trial in each group. (e) Mean (±SEM) PR-LTM
assessed 24 h after the reactivation trial in each group (Chow vs Curcumin; p<0.05) (from
Monsey et al., 2015).
The effects of curcumin on reconsolidation were also examined. Rats were habituated
and subsequently fear conditioned twenty-four hours later. Twenty-four hours after fear
conditioning, the rats were placed on either a regular diet or a curcumin diet for five days. On
day eight of the experiment (day six of the diet), the rats were brought back to a new context and
were given a reactivation (e.g. retrieval) trial, which consisted of a single CS tone presentation in
the absence of a footshock. Both groups showed similar levels of freezing during reactivation,
indicating that curcumin had no effect on the retrieval/reactivation of the memory. Rats were
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then tested for post-reactivation (PR)-STM two hours later and PR-LTM twenty-four hours later.
Both groups displayed no significant differences in PR-STM, but the curcumin group had
significantly impaired fear memory retention compared to the regular diet group during PR-LTM
(Figure 1.5d, e) This gives evidence that dietary curcumin impaired the reconsolidation of a
Pavlovian fear memory. Other experiments showed that the effect of curcumin on
reconsolidation was dependent on active retrieval of the fear memory; in the absence of
reactivation, curcumin had no effect on the retention of the fear memory (Figure 1.6). Therefore,
the effects of dietary curcumin on the reconsolidation of an auditory Pavlovian fear memory
were dependent on the retrieval of the fear memory.

Figure 1.6 – Dietary curcumin has no effect on a non-reactivated fear memory. (a) Schematic of
the behavioral protocol. (b) Mean (±SEM) post shock freezing in Chow (n = 8) and Curcumin (n
= 8) groups immediately after the conditioning trials. (c) Mean (±SEM) freezing in each group
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during the ‘no- reactivation’ trial. (d) Mean (±SEM) ‘PR’-STM assessed 2 h after the noreactivation trial in each group. (e) Mean (±SEM) ‘PR’-LTM assessed 24 h after the noreactivation trial in each group (from Monsey et al., 2015).
Although the above experiments indicate that curcumin can impair the reconsolidation of
a Pavlovian fear memory, curcumin was not tested in a way that fully captures what may occur
in the clinical world. Often, there is a gap between the trauma and the individual seeking
treatment. In order to mimic this circumstance, our lab ran an additional experiment in which a
full week passed between conditioning (day 2 of the experiment) and the start of the curcumin
diet (day 11 of the experiment). The results showed that curcumin did not impair PR-STM (day
16) but impaired PR-LTM (day 17) (Data Not Shown). Therefore, curcumin was shown to
impair the reconsolidation of an older, 14-day old, fear memory.
Finally, there is a question of whether the effects of curcumin on reconsolidation is due to
impairing the original memory. As described above, interfering with the reconsolidation of a
Pavlovian fear memory implies a weakening of the original memory (Alberini & LeDoux, 2013).
In order to test this, our lab compared the effects of dietary curcumin on the reconsolidation
process to two control chow groups that underwent extinction. The reasoning was that the
rodents who underwent extinction would be subject to reinstatement and renewal because the
original fear memory was still intact (as discussed above). The reconsolidation-curcumin group
would not be subject to reinstatement or renewal, since the original fear memory would be
weakened, presumably, by the curcumin manipulation. Our lab showed that the effects of
curcumin on reconsolidation were not subject to reinstatement or renewal (Data Not Shown).
These results suggest that a diet enriched with curcumin can significantly impair the
reconsolidation of a fear memory, and therefore impair the original fear memory.
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Rationale for Proposed Study
Although the preliminary data provide evidence that curcumin affects Pavlovian fear
memories, the delivery of curcumin in the diet is fraught with interpretive difficulties, including
issues of poor bioavailability and potential systemic effects that are unrelated to memory per se
(Anand, Kunnumakkara, Newman, & Aggarwal, 2007). Specifically, Phase I clinical trials have
reported low plasma and tissue levels of curcumin due to poor absorption, rapid metabolism, and
rapid systemic elimination (Anand et al., 2007). Further, there has yet to be a formal study on the
effects of dietary curcumin on the extinction of a Pavlovian fear memory. Finally, while
curcumin has been shown to readily enter the brain (Anand et al., 2007), the specific site of
action has not been systematically explored.
Accordingly, in the present dissertation, I will ask whether direct infusions of curcumin
into the LA can impair the consolidation and reconsolidation of a Pavlovian fear memory.
Further, I will explore a molecular mechanism by which curcumin modulates fear memory
consolidation and reconsolidation in the LA. Finally, I will explore whether curcumin has any
effect on fear memory extinction when administered in the diet or directly into the IL through
local infusions. These experiments will shed light on whether curcumin is having a direct effect
on the brain and, if so, its specific mechanism of action. The data will provide support for a
potential new pharmacological tool that can be used by clinicians to treat disorders characterized
by persistent traumatic memories. Therefore, this dissertation has the following aims:
Specific Aim 1: Does curcumin impair fear memory consolidation at the level of the
LA by inhibiting the IKK:NF-kB pathway? The first sets of experiment will assess whether
curcumin interferes with the consolidation of a Pavlovian fear memory at the level of the brain,
specifically within the LA, a key site of fear memory storage. Experiments to address this
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question will include behavioral and molecular studies utilizing local infusions of curcumin
directly into the LA following fear acquisition.
There is ample evidence suggesting that curcumin exerts its effects on the IKK:NF-kB
signaling pathway (Balasubramanyam et al., 2004; Jobin et al., 1999; Singh & Aggarwal, 1995).
Other lines of evidence suggest that the IKK:NF-kB signaling pathway directly interacts with
histone H3 to aid in phosphorylation and acetylation (Lubin & Sweatt, 2007; Quivy & Lint,
2004; Yamamoto, Verma, Prajapati, Kwak, & Gaynor, 2003). Finally, there is evidence that
histone H3 acetylation is directly related to IEG expression (Lubin & Sweatt, 2007; Maddox,
Schafe, & Ressler, 2013; Maddox, Watts, Doyère, & Schafe, 2013). Therefore, molecular
experiments will use Western blotting methods to examine the levels of phosphorylated IKK,
acetylated histone H3, and memory-related immediate early genes (IEGs) in the LA following
acquisition of a fear memory in rats given locally infused curcumin.
It is hypothesized that infusions of curcumin into the LA will impair the consolidation of
a fear memory, and it will be correlated with decreased activation of IKK, decreased histone H3
acetylation, and decreased IEG expression. Focusing on whether levels of phosphorylated IKK
and acetylated histone H3 are affected after conditioning and infusions will give evidence that
curcumin may exert its effects within the LA through its interaction with IKK:NF-kB signaling
pathway. Further, associated downregulation of memory-related IEGs, such as Arc and EGR-1,
will provide evidence of memory impairment at the molecular level.
Specific Aim 2: Is curcumin’s effect on fear memory reconsolidation dependent on
inhibition of the IKK:NF-kB pathway within the LA?
Our dietary studies suggested that curcumin interfered with the reconsolidation of a
Pavlovian fear memory by weakening the original fear memory. However, there is a question of
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whether these effects were localized to the LA. Therefore, in order to address this question, the
second set of experiments will include behavioral studies using local infusions of curcumin
directly into the LA following fear memory retrieval, and Western blotting methods to explore a
molecular mechanism by which curcumin regulates the reconsolidation of a fear memory in the
LA.
As mentioned above, curcumin’s effects may hinge on impairing activation of IKK, and
therefore affecting histone acetylation and IEG expression. Therefore, molecular experiments
will examine the levels of phosphorylated IKK, acetylated histone H3 and memory-related IEGs
in the LA following reactivation of a fear memory in rats given locally infused curcumin. It is
hypothesized that infusions of curcumin into the LA will impair the reconsolidation of a fear
memory, and it will be correlated with decreased activation of IKK, decreased histone H3
acetylation, and decreased memory-related IEG expression.
Specific Aim 3: Does curcumin affect extinction, and if so, are curcumin’s effects
localized at the level of the IL? One of the more pressing questions about curcumin was
whether it had any effect on extinction. Therefore, the third set of experiments are exploratory in
nature, first assessing whether dietary curcumin affects the extinction of a Pavlovian fear
memory at all. Experiments to address this question include behavioral studies using dietary
curcumin with a full and partial extinction paradigm. It is known that the retrieval of an
extinction memory involves the IL. Therefore, local infusions of curcumin directly into the IL
following extinction acquisition will assess whether curcumin is affecting extinction at the level
of the IL.
Further, I will use Western blotting methods to explore a molecular mechanism by which
curcumin regulates the extinction of a fear memory. Previous studies have shown that a decrease
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in IKK levels leads to the extinction of a contextual fear memory (de la Fuente et al., 2011), and
that curcumin inhibits the activation of the IKK:NF-kB inflammatory signaling pathway (Singh
& Aggarwal, 1995). Further, other lines of research have shown an involvement of histone H3
acetylation (Stafford, Raybuck, Ryabinin, & Lattal, 2012; Puckett & Lubin, 2011; Wei et al.,
2012; Zovkic & Sweatt, 2013) and IEG expression (Tedesco, Roquet, DeMis, Chiamulera, &
Monfils, 2014) in the IL during extinction retention. Therefore, molecular experiments will
examine the levels of phosphorylated IKK, acetylated histone H3, and memory-related IEGs in
the IL following acquisition of an extinction memory in rats given either dietary curcumin or
locally infused curcumin in the IL. It is hypothesized that dietary and infused curcumin will
impair the extinction of a fear memory and will decrease levels of IKK phosphorylation. This, in
turn, is hypothesized to have an effect on histone H3 acetylation and IEG expression in the IL.
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Chapter 2: Curcumin Impairs the Consolidation of a Pavlovian Fear Memory
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As stated above, newly acquired Pavlovian fear memories have been shown to be
inherently unstable, acquiring stability over time as they are ‘consolidated’ into long-term
representations in the brain (Apergis-Schoute, Debiec, Doyère, LeDoux, & Schafe, 2005;
Rodrigues, Farb, Bauer, LeDoux, & Schafe, 2004; Schafe et al., 2000; Schafe, Nadel, Sullivan,
Harris, & LeDoux, 1999; Schafe & LeDoux, 2000). The dietary experiments demonstrated that a
5-day diet of curcumin impaired the consolidation of a Pavlovian fear memory. However, it is
evident that the dietary experiments were fraught with interpretive difficulties, and questions
remained as to whether curcumin had any local effects within the brain. Therefore, for these first
sets of experiments, the focus was to determine whether local infusions of curcumin into the LA
impaired the consolidation of a Pavlovian fear memory.
Interestingly, the IKK:NF-kB inflammatory signaling pathway has been shown to
interact with p300:CBP (Bhatt & Ghosh, 2014; Yamamoto et al., 2003), a histone
acetyltransferase (HAT) critical for acetylating histone H3 at lysine residue 18 (Dancy & Cole,
2015). Further, p300:CBP has been demonstrated to be critical for the consolidation of a
Pavlovian fear memory (Maddox et al., 2013). Therefore, a second focus of these experiments
was to determine whether curcumin impaired the activation of the IKK:NF-kB pathway, leading
to impaired global histone H3 acetylation and impaired histone H3 acetylation at lysine residue
18. Based on evidence indicating that histone H3 acetylation leads to IEG expression (Lubin &
Sweatt, 2007), we also investigated whether infusions of curcumin into the LA after conditioning
leads to impaired memory-related IEG expression within the LA.
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Methods.
Subjects. Adult-male Sprague-Dawley rats (Envigo, U.S.A.), weighing 300-350g and
aged 2-3 months, were housed individually in plastic cages and maintained on a 12:12 hr
light/dark cycle with food and water provided ad libitum.
Surgery. Rats were anesthetized with i.p. administration of ketamine (100 mg/kg) and
xylazine (6.0 mg/kg) and implanted with 33-gauge stainless-steel guide cannulas (Plastics One,
Roanoke, VA) into the LA (AP: -3.0 mm, ML: ±5.0 mm, DV: -8.0 mm relative to Bregma).
Guide cannulas were secured to screws in the skull using a mixture of dental acrylic and cement,
and 28-gauge dummy cannulas were inserted into the guide to prevent obstruction. Buprenex
(0.2 mg/kg) was administered as an analgesic and rats were provided with at least five days postoperative recovery time. All surgical procedures were conducted under the guidelines provided
in the National Institutes of Health Guide for the Care and Use of Experimental Rats and were
approved by the Hunter College, CUNY Institutional Animal Care and Use Committee.
Drugs. Curcumin (Fisher Scientific, 95% curcumin (diferuloylmethane)) was dissolved in
100% DMSO to a 4 µg/µl stock solution and then diluted in ultrapure H2O to a final
concentration of 1µg/µl solution for infusion into the brain. Curcumin-treated rats received
bilateral intra-LA infusions of 1 µg curcumin in 0.5 µl solution. Vehicle-treated rats received
bilateral intra-LA infusions of an equal volume 50% DMSO in ultrapure H2O.
Pharmacology & Western blotting experiments. For experiments examining the effect of
curcumin on training-related regulation of phosphorylated IKK, histone acetylation, and EGR-1,
cannulated rats were habituated to handling, the conditioning chambers, and the testing chambers
(30min/day/chamber) for 4 days prior to auditory fear conditioning. Fear conditioning consisted
of 3 tone-shock pairings (30 sec, 5 kHz, 75 dB; 1.0 mA; ITI=2 mins). The conditioning chamber
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(Context A, Coulbourn Instruments) was a lit chamber with a grid floor. One hour after
conditioning, rats were infused with either curcumin (1 µg/side) or vehicle (0.5 µl/side). Thirty
minutes later (90 min following training) rats were sacrificed, and brains were removed and
frozen at -80ºC until processed. This time point was chosen based on previous findings
indicating that upregulation of our target molecular pathways can be captured during this time
period (Maddox & Schafe, 2011b; Maddox et al., 2011; Ploski et al., 2008). An additional group
of “Naïve-Vehicle” rats were handled and habituated but not exposed to the training chamber
prior to infusion of vehicle (0.5 µl/side) and were sacrificed 30 min following infusions.
Punches containing the LA were obtained with a 1 mm punch tool (Fine Science Tools,
Foster City, CA) from 400-µm-thick sections taken on a sliding freezing microtome. Punches
were manually dounced in 100 µl of ice-cold hypotonic lysis buffer [10 mM Tris-HCl, pH
7.5, 1 mM EDTA, 2.5 mM sodium pyrophosphate, 1 mM phenylmethylsulfonyl fluoride, 1 mM
b-glycerophosphate, 1% Igepal CA-630, 1% protease inhibitor cocktail (Sigma) and 1 mM
sodium orthovanadate]. Sample buffer was immediately added to the homogenates, and the
samples were boiled for 4 min. Homogenates were electrophoresed on 18% Tris-HCl gels and
blotted to Immobilon-P (Millipore, Bedford, MA). Western blots were then blocked in TTBS
buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.05% Tween-20) with 5% dry milk and
then incubated with the appropriate primary antibody [anti-phospho-IKK alpha/beta, 1:2,000,
Cell Signaling; anti-IKK alpha (‘total IKK’), 1:2,000, Cell Signaling; anti-acetyl-H3 (pan),
1:3,000, Millipore; anti-acetyl-H3Lys18, 1:1,000, Cell Signaling; anti-H3 (‘total H3’), 1:5,000,
Millipore; anti-Egr-1, 1:1,000, Santa Cruz]. Blots were then incubated with anti-rabbit antibody
conjugated to horseradish peroxidase (Cell Signaling, Danvers, MA) and developed using West
Dura chemiluminescent substrate (Pierce Laboratories, Rockford, IL). Western blots were
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developed in the linear range used for densitometry. Densitometry was conducted using Image J
software. To control for inconsistencies in loading, optical densities for total IKK, total histone
and Egr-1 proteins were normalized to GAPDH protein (1:20,000; Abcam). Acetyl-histone
proteins were normalized to total-histone protein and phosphoIKK-α proteins were normalized to
total IKK-α protein. Data were normalized to the average value of naïve controls and analyzed
using ANOVA.
Behavioral experiments. Rats were handled for 2 days prior to conditioning. On the
second handling day, dummy cannulas were removed to check for patency. Rats were then
habituated to Context A for 15 minutes (Day 1). The following day (Day 2), rats were placed in
Context A and presented with 3 tone-shock pairings consisting of a 30 sec, 5 kHz, 75 dB tone
that co-terminated with a 1 sec, 1.0 mA foot shock (ITI=2 min). One hour later, rats received
intra-LA infusion of either curcumin (0.5 µl/side) or vehicle (0.5 µl/side). Infusions were made
over 4 mins and the infusion cannulas were left in place for at least 2 min following infusion to
facilitate diffusion throughout the LA. One group of rats was tested for short-term memory
(STM), 3 hours after infusions, by presenting 3 tones (30 sec, 5 kHz, 75 dB; ITI=2 min) in
Context B, which consisted of a dark chamber with a black plastic floor that was washed with
peppermint soap. Another group of rats received a long-term memory (LTM) test 24 hours later
(Day 3), which consisted of 5 tone presentations (30 sec, 5 kHz, 75 dB) and was conducted in
Context B. Rats used to examine whether the effects of curcumin on consolidation was
temporally constrained were trained and tested under identical parameters, however they
received intra-LA infusions 6 hours after conditioning.
Each behavioral test was video recorded for subsequent scoring by an observer who was
blind to the experimental conditions. Freezing was defined as a lack of movement, excluding that
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necessary for respiration, and was quantified as a percentage of the amount of time the rat spent
engaged in freezing behavior during the CS presentations. All data were analyzed with ANOVA
and Tukey’s post-hoc t-tests. Repeated measures ANOVAs were used for multiple trial
comparisons. Differences were considered significant if p <0.05. Only data from those rats with
bilaterally well-placed cannulas within the borders of the LA were included in the analyses.
Results.
Infusion of curcumin impairs phosphorylation of IkB kinase, histone acetylation and Egr-1
expression in the LA during consolidation of a fear memory
Previous studies have shown that fear memory consolidation requires IKK activation,
histone H3 acetylation, and the expression of the immediate early genes Egr-1 and Arc in the LA
(Yeh, Lin, Lee, & Gean, 2002). For IKK activity, we focused on the IKK-a subunit, since
research has shown that only the IKK-a subunit is regulated by fear memory retrieval (Lubin &
Sweatt, 2007).
In our first series of experiments, we asked whether intra-LA infusion of curcumin would
impair training-related regulation of each of these proteins. Rats were fear conditioned with three
pairings of a tone (conditioned stimulus; CS) that co-terminated with a footshock (unconditioned
stimulus; US). One hour following fear memory acquisition, rats received intra-LA infusion of
either vehicle (0.5 µl/side) or curcumin (1 µg/side; 0.5 µl) and were then sacrificed 30 min later
(90 min after conditioning; Fig 2.1). This time point was chosen based on previous observations
that consolidation of an auditory fear memory leads to an increase in histone H3 acetylation that
is most prominent at 90 min following training (Monsey, Ota, Akingbade, Hong, & Schafe,
2011).
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All rats exhibited equivalent post-shock freezing during training [Vehicle vs. Curcumin;
F (1,68) =0.67, p > 0.05; data not shown]. Consolidation of the fear memory led to a significant
increase in IKK-α phosphorylation in the LA relative to Naive controls. This upregulation was
blocked by intra-LA infusion of curcumin [F (2,18) = 5.38, p < 0.05; Fig 2.1d). Tukey’s post-hoc ttests revealed that the training-vehicle group was significantly different from naïve-vehicle
controls (p < 0.05). Further, the training-curcumin group was significantly different from the
training-vehicle group (p < 0.05) yet did not differ from the naïve-vehicle group (p > 0.05).
Moreover, no difference was observed in total (non-phosphorylated) protein levels of IKK-α [F
(2,18) =

0.38; Fig 2.1d]. Finally, no difference was observed in the expression of GAPDH [F (2,18)

= 0.08; data not shown], which was used as a loading control in this and all subsequent Western
blotting experiments.
We next examined the effects of intra-LA infusion of curcumin on training-related
histone H3 acetylation in the LA. In these experiments, we probed our blots with both a ‘pan’
acetyl-H3 antibody and an antibody that specifically recognizes acetylation of histone H3 at
lysine residue 18 (H3K18). We chose to examine H3K18 because previous research has shown
that IKK interacts with the p300/CBP HAT (Yamamoto et al., 2003), which binds specifically at
the lysine 18 residue of the H3 histone protein (Bedford & Brindle, 2012). Consolidation of the
fear memory led to a significant increase in overall H3 acetylation [F (2,18) = 9.16, p < 0.05; Fig
2.1c] and H3K18 acetylation [F (2,18) = 7.10, p < 0.05; Fig 1c] in the LA relative to Naive
controls, and each of these effects was blocked by intra-LA infusion of curcumin.
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Figure 2.1. Intra-LA infusion of curcumin impairs fear memory training-related
phosphorylation of IKK-α, acetylation of histone H3, and expression of Egr-1. (a) Schematic of
the behavioral protocol. Rats were fear conditioned with 3 tone-shock pairings. One hour after
training, rats received intra-LA infusion of either vehicle (n = 8) or curcumin (1 µg/side; n = 8)
and were sacrificed 30 min later. A third (Naïve) group (n = 8) did not receive conditioning and
was infused with vehicle 30 mins prior to sacrifice. (b) Western blot analysis (mean ± SEM) of
Egr-1 and Arc from LA homogenates from Naïve-Veh, Train-Veh and Train-Curc groups.
Levels of Egr-1 and Arc were normalized to GAPDH and expressed as a percentage of the
Naïve-Veh group. * p < 0.05 relative to Train-Veh group. (c) Western blot analysis (mean ±
SEM) of acetylated histone H3 (Pan), acetylated H3-Lysine 18, and total (non-acetylated) H3
from LA homogenates from Naïve-Veh, Train-Veh and Train-Curc groups. Levels of total H3
were first normalized to GAPDH. Levels of acetyl-H3 (pan) and acetyl-H3-Lys18 were then
normalized to total H3 and expressed as a percentage of the Naïve-Veh group. * p < 0.05 relative
to Train-Veh group. (d) Western blot analysis (mean ± SEM) of phosphorylated and total (nonphosphorylated) IKK-α from LA homogenates from Naïve-Vehicle (Naïve-Veh), TrainingVehicle (Train-Veh) and Training-Curcumin (Train-Curc) groups. Levels of total IKK-α were
first normalized to GAPDH. Levels of phospho-IKK-α were then normalized to total IKK-α and
expressed as a percentage of the Naïve-Veh group. * p < 0.05 relative to Train-Veh. (e)
Representative Western blots for each experiment.
Tukey’s post-hoc t-tests revealed that the training-vehicle group was significantly different from
naïve-vehicle controls (p < 0.05) in both experiments. Further, the training-curcumin group was
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significantly different from the training-vehicle group (p < 0.05) yet did not differ from the
naïve-vehicle group (p > 0.05) in both experiments. Moreover, no difference was observed in
total protein levels of histone H3 [F (2,18) = 0.05; Figure 2.1c].
Finally, we examined the impact of intra-LA infusion of curcumin on Arc and Egr-1
expression in the LA. Consolidation of the fear memory led to a significant increase in Arc
expression in the LA relative to Naive controls [F (2,18) = 6.03, p < 0.05; Fig 2.1b)]. Tukey’s
post-hoc t-tests revealed that the training-vehicle group was significantly different from naïvevehicle controls (p < 0.05). Further, the training-curcumin group did not differ from the trainingvehicle group (p > 0.05) but was significantly different from the naïve-vehicle group (p < 0.05).
Consolidation of the fear memory led to a significant increase in Egr-1 expression in the LA
relative to Naive controls that was impaired by intra-LA infusion of curcumin [F (2,18) = 8.75, p <
0.05; Fig 2.1b)]. Tukey’s post-hoc t-tests revealed that the training-vehicle group was
significantly different from naïve-vehicle controls (p < 0.05). Further, the training-curcumin
group was significantly different from the training-vehicle group (p < 0.05) yet did not differ
from the naïve-vehicle group (p > 0.05).
Thus, conditioning of an auditory fear memory leads to significant regulation of IkB
kinase, histone H3 acetylation and immediate early gene expression in the LA. Further, the
training-related regulation of each of these molecular signaling cascades was significantly
impaired by intra-LA infusion of curcumin, with the exception of the immediate early gene Arc.
Intra-LA infusion of curcumin impairs fear memory consolidation
We next examined the effect of intra-LA infusions of curcumin on fear memory
consolidation. Rats were trained and infused as in our Western blot experiments (above), and
then given a test of long-term memory (LTM) ~24 hrs after conditioning. Separate groups of
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rats were trained, infused, and given a test of short-term memory (STM) 3 hrs after retrieval (Fig
2.2a). For the LTM group, all rats exhibited equivalent post-shock freezing during training
[Vehicle vs. Curcumin; F (1,13) = 2.96; Fig 2.2b]. The following day, curcumin-treated rats
exhibited significantly impaired LTM compared to the vehicle group; the repeated measures
ANOVA (group by trial) revealed a significant main effect of trial [F (4,52) = 5.23, p < 0.01], and
a significant main effect of group [Vehicle vs. Curcumin; F (1,13) = 7.06, p < 0.05] but no
significant interaction [Group vs. Trial; F (4,52) = 0.21, p >0.05; Fig 2.2c]. Cannula placements for
both groups can be found in Figure 2.2d.
In contrast to LTM, intra-LA infusion of curcumin had no effect on STM. All rats exhibited
equivalent post-shock freezing during training [Vehicle vs. Curcumin; F (1,12) = 0.04; Fig 2.2e].
Three hours after infusions, both groups exhibited equivalent levels of freezing during the STM
test; the repeated measures ANOVA (group by trial) revealed no main effect of trial [F (2,24) =
1.96, p > 0.05], no main effect of group [Vehicle vs. Curcumin; F (1,12) = 0.15, p > 0.05] and no
significant interaction [Group vs. Trial; F (2,24) = 0.09, p >0.05; Fig 2.2f]. This indicates that
curcumin has no effect on the acquisition of a fear memory when the animals are tested shortly
after training and infusion. Cannula placements for both groups can be found in Figure 2.2g.
Collectively, this pattern of findings (impaired LTM, intact STM) suggests that intra-LA infusion
of curcumin impaired the consolidation of a fear memory.
The consolidation deficit induced by infused curcumin is temporally specific. Next, we
observed in a separate experiment that the effect of curcumin on fear memory consolidation is
temporally constrained; when rats were given intra-LA infusions of curcumin 6 hrs following
training there was no effect on LTM. All rats exhibited equivalent post-shock freezing during
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Figure 2.2. Intra-LA infusion of curcumin impairs fear memory consolidation. (a) Schematic of
the behavioral protocol. Rats were fear conditioned and infused with either vehicle or curcumin
as in Figure 2.1. Separate groups of rats were then tested for either STM (3 hrs later) or LTM (24
hrs later). (b) Percent post-shock freezing (mean ± SEM) during fear conditioning in rats infused
with either vehicle (n = 8) or curcumin (n = 8) following training and later tested for LTM. (c)
Percent freezing (mean ± SEM) during the LTM test in vehicle and curcumin groups. (d)
Cannula placements for rats infused with either vehicle (black circles) or curcumin (grey circles)
and tested for LTM. (e) Percent post-shock freezing (mean ± SEM) during fear conditioning in
rats infused with either vehicle (n = 8) or curcumin (n = 8) following conditioning and later
tested for STM. (f) Percent freezing (mean ± SEM) during the STM test in vehicle and curcumin
groups. (g) Cannula placements for rats infused with either vehicle (black circles) or curcumin
(grey circles) and tested for STM.
training [Vehicle vs. Curcumin; F (1,12) = 0.09; Fig 2.3b]. The ANOVA (group by trial) for LTM
revealed no significant main effect of trial [pre-CS vs. CS; F (4,48) = 1.77, p > 0.05], and no
significant main effect of group [Vehicle vs. Curcumin; F (1,12) = 0.011, p>.05] or significant
interaction [Group vs. Trial; F (4,48) = 1.12, p >0.05; Fig 2.3c]. Cannula placements for both

43

groups can be found in Figure 2.3d. Thus, intra-LA infusion of curcumin within a narrow
window (~1 hr) following training can significantly impair the consolidation of a fear memory.
Intra-LA infusion of curcumin at a lower dose has a moderate effect on the consolidation of
a fear memory
In each of our previous experiments, we infused 1.0µl of curcumin bi-laterally. We next
asked whether a curcumin dose of 0.1µl could impair the consolidation of a fear memory. Rats
were fear conditioned as before, followed by intra-LA infusion of a 0.1µl dose of either vehicle
or curcumin (Fig 2.3a). Both groups showed equivalent post-shock freezing during training [F
(1,13) =

3.21, p>.05; Fig 2.3e]. On the following day, curcumin-treated rats exhibited a slightly

Figure 2.3. The consolidation deficit induced by intra-LA curcumin infusion is constrained to a
specific temporal window and dependent on the dose of curcumin. (a) Schematic of the
behavioral protocol for the delayed infusion experiment. Rats were treated identically to those in
Figure 2.2 with the exception that vehicle or curcumin infusion was given 6 hrs following
training. All rats were then tested for LTM. (b) Percent post-shock freezing (mean ± SEM)
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during fear conditioning in rats infused with either vehicle (n = 8) or curcumin (n = 8) 6 hrs after
conditioning and later tested for LTM. *p<0.05 relative to the pre-CS period. (c) Percent freezing
(mean ± SEM) during the LTM test in vehicle and curcumin groups. (d) Cannula placements for
rats infused with either a lower dose of vehicle (black circles) or curcumin (grey circles) 6 hrs
following conditioning and tested for LTM. (e) Percent post-shock freezing (mean ± SEM)
during fear conditioning in rats infused with either vehicle (n = 8) or curcumin (n = 8). Rats were
treated identically to those in Figure 2.2 with the exception that they were infused with a 0.1µl
dose of curcumin. All rats were then tested 24 hrs later for LTM. (f) Percent freezing (mean ±
SEM) during the LTM test in vehicle and curcumin groups. (g) Cannula placements for rats
infused with either a lower dose of vehicle (black circles) or curcumin (grey circles) following
conditioning and tested for LTM.
lower, but not significant, freezing percentage during LTM testing, relative to the vehicle-infused
controls; the ANOVA (group by trial) revealed a main effect of trial [F (4,52) = 3.11, p < 0.05],
and no significant main effect of group [Vehicle vs. Curcumin; F (1,13) = 3.33, p>0.05], and no
significant interaction [Group vs. Trial; F (4,52) = 0.99, p >0.05; Figure 2.3f]. Cannula placements
for both groups can be found in Figure 2.3g. Thus, an infusion of curcumin into the LA, at a
lower dose, does not significantly impair the consolidation of a fear memory.
Discussion
Our initial exploration of dietary curcumin revealed that curcumin impaired immediate
early gene activation associated with the consolidation of a Pavlovian fear memory. Further, we
observed that dietary curcumin behaviorally impaired the consolidation of a Pavlovian fear
memory (Monsey et al., 2015). In these first set of experiments, we have provided evidence that
direct infusions of curcumin into the LA can impair the consolidation of a Pavlovian fear
memory. Specifically, an infusion of curcumin one hour after conditioning impairs IKK-α
signaling, which subsequently impairs histone acetylation and Egr-1 activation, all critical for the
consolidation of a Pavlovian fear memory. Further, this effect was constrained to a specific time
window, revealing that curcumin is affecting a pathway that is critically needed at a specific time
point. Finally, we explored the effect of a lower dose of infused curcumin on the consolidation of
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a Pavlovian fear memory. We found that infusions of a lower dose of curcumin resulted in lower
levels of freezing that trended towards significance. This showed that the effects of infused
curcumin may be dose dependent.
Much of the work on curcumin has demonstrated that it inhibits the IKK:NF-kB
signaling pathway (Jobin et al., 1999; Singh & Aggarwal, 1995). Relatively few studies have
investigated the role of the IKK:NF-kB signaling pathway in learning and memory. One study
has implicated coordinated IKK-HAT activity in hippocampal-dependent memory and synaptic
plasticity (Lubin & Sweatt, 2007), and only a few studies have implicated the IKK:NF-kB
signaling pathway in auditory fear conditioning (Si et al., 2012; Yeh et al., 2004). In these first
set of experiments, we demonstrated that intra-LA infusion of curcumin significantly impairs
training-related IKK-α phosphorylation and the consolidation of an auditory Pavlovian fear
memory. Our findings provide further evidence that IKK-α activity plays a critical role in
Pavlovian fear memory consolidation.
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Chapter 3: Curcumin Impairs the Reconsolidation of a Pavlovian Fear Memory
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Our initial exploration into the effects of dietary curcumin on reconsolidation revealed
that a 5-day diet of curcumin impaired the reconsolidation of a Pavlovian fear memory. Much
like the consolidation experiments, the dietary-reconsolidation experiments left a question as to
whether curcumin was exerting local effects at level of the LA. Thus, in these sets of
experiments, we explored the direct effects of curcumin in the LA on fear memory
reconsolidation and associated molecular signaling pathways.
We first investigated whether intra-LA infusions of curcumin would disrupt retrievalrelated regulation of IKK-a phosphorylation, and subsequently affect global histone H3
acetylation, histone H3 acetylation at the specific lysine residue 18, and memory-related IEG
expression in the LA. Next, we examined whether direct infusions of curcumin into the LA can
effectively impair the reconsolidation of both a recently formed and an older, well-established,
Pavlovian fear memory.
Materials & Methods
Subjects. Adult-male Sprague-Dawley rats (Envigo, U.S.A.), weighing 300-350g and
aged 2-3 months, were housed individually in plastic cages and maintained on a 12:12 hr
light/dark cycle with food and water provided ad libitum.
Surgery. Rats were anesthetized with i.p. administration of ketamine (100 mg/kg) and
xylazine (6.0 mg/kg) and implanted with 33-gauge stainless-steel guide cannulas (Plastics One,
Roanoke, VA) into the LA (AP: -3.0 mm, ML: ±5.0 mm, DV: -8.0 mm relative to Bregma).
Guide cannulas were secured to screws in the skull using a mixture of dental acrylic and cement,
and 33-gauge dummy cannulas were inserted into the guide to prevent obstruction. Buprenex
(0.2 mg/kg) was administered as an analgesic and rats were provided with at least five days postoperative recovery time. All surgical procedures were conducted under the guidelines provided
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in the National Institutes of Health Guide for the Care and Use of Experimental Rats and were
approved by the Hunter College, CUNY Institutional Animal Care and Use Committee.
Drugs. Curcumin (Fisher Scientific, 95% curcumin (diferuloylmethane)) was dissolved in
100% DMSO to a 4 µg/µl stock solution and then diluted in ultrapure H2O to a final
concentration of 1µg/µl solution for infusion into the brain. Curcumin-treated rats received
bilateral intra-LA infusions of 1 µg curcumin in 0.5 µl. Vehicle-treated rats received bilateral
intra-LA infusions of an equal volume 50% DMSO in ultrapure H2O.
Pharmacology & Western blotting experiments. For Western blotting experiments
examining the effect of curcumin on retrieval-related regulation of phosphorylated IKK, histone
acetylation, and EGR-1, cannulated rats were habituated to handling, the conditioning chambers,
and the testing chambers (30min/day/chamber) for 4 days prior to auditory fear conditioning.
Fear conditioning consisted of 3 tone-shock pairings (30 sec, 5 kHz, 75 dB; 1.0 mA; ITI=2
mins). The conditioning chamber (Context A) was a lit chamber with a grid floor, while the
reactivation chamber (Context B) consisted of a dark chamber (no lights) with a black plastic
floor, which was washed with a peppermint soap (Dr. Bronner’s Pure-Castile) immediately
before reactivation. Twenty-four hours after conditioning, rats were given an auditory fear
memory reactivation session consisting of a single 30 sec, 5 kHz, 75 dB tone which was
administered in Context B. One hour later, rats were infused with either curcumin or vehicle (0.5
µl/side). Thirty minutes later (90 min following training) rats were sacrificed, and brains were
removed and frozen at -80ºC until processed. This time point was chosen because it allowed us
to successfully capture the upregulation of our target molecular pathways (Lubin & Sweatt,
2007; Maddox & Schafe, 2011a; Maddox et al., 2013; Yeh et al., 2004). An additional group of
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“Naïve-Vehicle” rats were handled and habituated but not exposed to the training or testing
chamber prior to infusion of vehicle (0.5 µl/side) and were sacrificed 30 min following infusions.
Punches containing the LA were obtained with a 1 mm punch tool (Fine Science Tools,
Foster City, CA) from 400-µm-thick sections taken on a sliding freezing microtome. Punches
were manually dounced in 100 µl of ice-cold hypotonic lysis buffer [10 mM Tris-HCl, pH
7.5, 1 mM EDTA, 2.5 mM sodium pyrophosphate, 1 mM phenylmethylsulfonyl fluoride, 1 mM bglycerophosphate, 1% Igepal CA-630, 1% protease inhibitor cocktail (Sigma) and 1 mM sodium
orthovanadate]. Sample buffer was immediately added to the homogenates, and the samples were
boiled for 4 min. Homogenates were electrophoresed on 18% Tris-HCl gels and blotted to
Immobilon-P (Millipore, Bedford, MA). Western blots were then blocked in TTBS buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.05% Tween-20) with 5% dry milk and then
incubated with the appropriate primary antibody [anti-phospho-IKK alpha/beta, 1:2,000, Cell
Signaling; anti-IKK alpha (‘total IKK’), 1:2,000, Cell Signaling; anti-acetyl-H3 (pan), 1:3,000,
Millipore; anti-acetyl-H3Lys18, 1:1,000, Cell Signaling; anti-H3 (‘total H3’), 1:5,000, Millipore;
anti-Egr-1, 1:1,000, Santa Cruz]. Blots were then incubated with anti-rabbit antibody conjugated
to horseradish peroxidase (Cell Signaling, Danvers, MA) and developed using West Dura
chemiluminescent substrate (Pierce Laboratories, Rockford, IL). Western blots were developed in
the linear range used for densitometry. Densitometry was conducted using Image J software. To
control for inconsistencies in loading, optical densities for total IKK, total histone and Egr-1
proteins were normalized to GAPDH protein (1:20,000; Abcam). Acetyl-histone proteins were
normalized to total-histone protein and phosphoIKK-α proteins were normalized to total IKK-α
protein. Data were normalized to the average value of naïve controls and analyzed using a oneway ANOVA.
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Behavioral experiments. Rats were handled for 2 days prior to conditioning. On the
second handling day, dummy cannulas were removed to check for patency. Rats were then
habituated to Context A for 15 minutes (Day 1). The following day (Day 2), rats were placed in
Context A and presented with 3 tone-shock pairings consisting of a 30 sec, 5 kHz, 75 dB tone
that co-terminated with a 1 sec, 1.0 mA foot shock (ITI=2 min). The next day (Day 3), rats were
placed in Context B and exposed to either a single tone presentation, to serve as a memory
reactivation trial, or no tone presentation, to serve as a ‘no reactivation’ trial. One hour later, rats
received intra-LA infusion of either curcumin or vehicle (0.5 µl/side). Infusions were made over
4 mins and the infusion cannulas were left in place for at least 2 min following infusion to
facilitate diffusion throughout the LA. One group of rats was tested for post-reactivation shortterm memory (PR-STM) 3 hours after infusions, consisting of the presentation of 3 tones (30 sec,
5 kHz, 75 dB; ITI=2 min) in Context B. Another group of rats received a post-reactivation longterm memory (PR-LTM) test 24 hours later (Day 4), which consisted of 5 tone presentations (30
sec, 5 kHz, 75 dB; ITI=2 min) and was conducted in Context B. Rats used to examine the effect
of curcumin on the reconsolidation of an older, well-consolidated memory were trained and
tested under identical parameters, however they were returned to their home cage for 2 weeks
following conditioning prior to reactivation, intra-LA infusions, and the subsequent PR-LTM
test.
Each behavioral test was video recorded for subsequent scoring by an observer who was
blind to the experimental conditions. Freezing was defined as a lack of movement, excluding that
necessary for respiration, and was quantified as a percentage of the amount of time the rat spent
engaged in freezing behavior during the CS presentations. All data were analyzed with ANOVA
and Tukey’s post-hoc t-tests. Repeated measures ANOVAs were used for multiple trial
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comparisons. Differences were considered significant if p <0.05. Only data from those rats with
bilaterally well-placed cannulas within the borders of the LA were included in the analyses.
Results
Curcumin impairs phosphorylation of IkB kinase, histone acetylation and Egr-1 expression
in the LA following retrieval of a fear memory
Previous studies have shown that fear memory reconsolidation requires IKK activation
(Si et al., 2012), histone acetylation (Maddox & Schafe, 2011a, 2011b; Maddox, Watts, &
Schafe, 2013; Maddox, Monsey, & Schafe, 2011; Monsey, Ota, Akingbade, Hong, & Schafe,
2011; Ploski et al., 2008), and the expression of the immediate early gene Egr-1 (Maddox &
Schafe, 2011a) in the LA. Further, work in the hippocampus has indicated that each of these
signaling pathways interact in an elaborate manner during retrieval of a contextual fear memory
(Lubin & Sweatt, 2007). Given that curcumin is known to potently target both IkB kinase
signaling and histone acetylation (Balasubramanyam et al., 2004; Jobin et al., 1999) in other
biological systems, in our first series of experiments we asked whether intra-LA infusion of
curcumin would similarly impair retrieval-related regulation of each of these proteins in the LA.
Rats were fear conditioned with three pairings of a tone (conditioned stimulus; CS) that coterminated with a footshock (unconditioned stimulus; US), followed by a fear memory retrieval
(or ‘reactivation’) session 24 hours later that consisted of a single tone CS presentation. One hour
following fear memory reactivation, rats received intra-LA infusion of either vehicle (0.5 µl/side)
or curcumin (1 µg/side; 0.5 µl) and were then sacrificed 30 min later (90 min after retrieval; Fig
3.1a). This time point was chosen based on previous observations that retrieval of an auditory
fear memory leads to an increase in histone H3 acetylation that is most prominent at 90 min
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following retrieval (Maddox & Schafe, 2011a), and that IKK-α is upregulated 1 hour following
fear memory retrieval (Lubin & Sweatt, 2007).

Figure 3.1. Intra-LA infusion of curcumin impairs fear memory retrieval-related
phosphorylation of IKK-α, acetylation of histone H3, and expression of Egr-1. (a) Schematic of
the behavioral protocol. Rats were fear conditioned with 3 tone-shock pairings followed by a
reactivation session consisting of a single tone CS presentation 24 hrs later. One hour after
retrieval, rats received intra-LA infusion of either vehicle (n = 7) or curcumin (1 µg/side; n = 7)
and were sacrificed 30 min later. A third (Naïve) group (n = 7) did not receive conditioning or
reactivation and was infused with vehicle 30 mins prior to sacrifice. (b) Percent freezing (mean ±
SEM) during the memory reactivation trial in rats prior to intra-LA infusion of vehicle or
curcumin. *p<0.05 relative to the pre-CS period. (c) Western blot analysis (mean ± SEM) of
phosphorylated and total (non-phosphorylated) IKK-α from LA homogenates from NaïveVehicle (Naïve-Veh), Reactivated-Vehicle (React-Veh) and Reactivated-Curcumin (React-Curc)
groups. Levels of total IKK-α were first normalized to GAPDH. Levels of phospho-IKK-α were
then normalized to total IKK-α and expressed as a percentage of the Naïve-Veh group. * p < 0.05
relative to React-Veh. (d) Western blot analysis (mean ± SEM) of acetylated histone H3 (Pan),
acetylated H3-Lysine 18, and total (non-acetylated) H3 from LA homogenates from Naïve-Veh,
React-Veh and React-Curc groups. Levels of total H3 were first normalized to GAPDH. Levels
of acetyl-H3 (pan) and acetyl-H3-Lys18 were then normalized to total H3 and expressed as a
percentage of the Naïve-Veh group. * p < 0.05 relative to React-Veh group. (e) Western blot
analysis (mean ± SEM) of Egr-1 from LA homogenates from Naïve-Veh, React-Veh and ReactCurc groups. Levels of Egr-1 were normalized to GAPDH and expressed as a percentage of the
Naïve-Veh group. * p < 0.05 relative to React-Veh group. (f) Representative Western blots for
each experiment.
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All rats exhibited equivalent post-shock freezing during training [Vehicle vs. Curcumin;
F (1,12) = 1.72, p > 0.05; data not shown]. Further, rats designated to be infused with either vehicle
or curcumin exhibited significant and equivalent memory recall during the memory reactivation
session; the ANOVA (group by trial) revealed a significant main effect of trial [pre-CS vs. CS;
F(1,24) = 963.8, p < 0.01] but no significant effect of group [Vehicle vs. Curcumin; F(1,24) =
0.1785, p > 0.05], indicating that both groups exhibited significant and equivalent memory
retrieval during the reactivation trial (Fig 3.1b). Retrieval of the fear memory led to a significant
increase in IKK-α phosphorylation in the LA relative to Naive controls that was blocked by
intra-LA infusion of curcumin [F (2,18) = 7.597, p < 0.05; Fig 3.1c). Tukey’s post-hoc t-tests
revealed that the reactivated-vehicle group was significantly different from naïve-vehicle
controls (p < 0.05). Further, the reactivated-curcumin group was significantly different from the
reactivated-vehicle group (p < 0.05) yet did not differ from the naïve-vehicle group (p > 0.05).
Moreover, no difference was observed in total (non-phosphorylated) protein levels of IKK-α [F
(2,18) =

0.5145; Fig 3.1c]. Finally, no difference was observed in the expression of GAPDH [F

(2,18) =

1.314; data not shown], which was used as a loading control in this and all subsequent

Western blotting experiments.
We next examined the effects of intra-LA infusion of curcumin on retrieval-related
histone H3 acetylation in the LA. In these experiments, we probed our blots with both a ‘pan’
acetyl-H3 antibody and an antibody that specifically recognizes acetylation of histone H3 at
lysine residue 18 (H3K18). We chose to examine H3K18 because previous research has shown
that IKK interacts with the p300/CBP HAT (Yamamoto et al., 2003), which binds specifically at
the lysine 18 residue of the H3 histone protein (Bedford & Brindle, 2012). Retrieval of the fear
memory led to a significant increase in overall H3 acetylation [F (2,18) = 11.63, p < 0.05; Fig
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3.1d] and H3K18 acetylation [F (2,18) = 8.021, p < 0.05; Fig 3.1d] in the LA relative to Naive
controls, and each of these effects was blocked by intra-LA infusion of curcumin. Tukey’s posthoc t-tests revealed that the reactivated-vehicle group was significantly different from naïvevehicle controls (p < 0.05) in both experiments. Further, the reactivated-curcumin group was
significantly different from the reactivated-vehicle group (p < 0.05) yet did not differ from the
naïve-vehicle group (p > 0.05) in both experiments. Moreover, no difference was observed in
total protein levels of histone H3 [F (2,18) = 0.2122; Figure 3.1d].
Finally, we examined the impact of intra-LA infusion of curcumin on Egr-1 expression in
the LA. Retrieval of the fear memory led to a significant increase in Egr-1 expression in the LA
relative to Naive controls that was impaired by intra-LA infusion of curcumin [F (2,18) = 6.267, p
< 0.05; Fig 3.1e)]. Tukey’s post-hoc t-tests revealed that the reactivated-vehicle group was
significantly different from naïve-vehicle controls (p < 0.05). Further, the reactivated-curcumin
group was significantly different from the reactivated-vehicle group (p < 0.05) yet did not differ
from the naïve-vehicle group (p > 0.05).
Thus, consistent with previous findings (Lubin & Sweatt, 2007; Maddox & Schafe,
2011a, 2011a; Si et al., 2012), retrieval of an auditory fear memory leads to significant regulation
of IkB kinase, histone H3 acetylation and Egr-1 expression in the LA. Further, the retrievalrelated regulation of each of these molecular signaling cascades is significantly impaired by
intra-LA infusion of curcumin.
Intra-LA infusion of curcumin impairs fear memory reconsolidation
We next examined the effect of intra-LA infusion of curcumin on fear memory
reconsolidation. Rats were trained, reactivated and infused as in our Western blot experiments
(above), and then given a test of post-reactivation long-term memory (PR-LTM) ~24 hrs after
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retrieval. Separate groups of rats were trained, reactivated, infused and given a test of postreactivation short-term memory (PR-STM) 3 hrs after retrieval (Fig 3.2a). All rats exhibited
equivalent post-shock freezing during training [Vehicle vs. Curcumin; F (1,10) = 1.64; Fig 3.2b].

Figure 3.2. Intra-LA infusion of curcumin impairs fear memory reconsolidation. (a) Schematic
of the behavioral protocol. Rats were fear conditioned, reactivated and infused with either
vehicle or curcumin as in Figure 1. Separate groups of rats were then tested for either PR-STM
(3 hrs later) or PR-LTM (24 hrs later). (b) Percent post-shock freezing (mean ± SEM) during
fear conditioning in rats infused with either vehicle (n = 6) or curcumin (n = 6) following
reactivation and later tested for PR-LTM. (c) Percent freezing (mean ± SEM) during the memory
reactivation trial in rats infused with vehicle or curcumin and later tested for PR-LTM. *p<0.05
relative to the pre-CS period. (d) Percent freezing (mean ± SEM) during the PR-LTM test in
vehicle and curcumin groups. (e) Cannula placements for rats infused with either vehicle (black
circles) or curcumin (grey circles) and tested for PR-LTM. (f) Percent post-shock freezing
(mean ± SEM) during fear conditioning in rats infused with either vehicle (n =7) or curcumin (n
= 7) following reactivation and later tested for PR-LTM. (g) Percent freezing (mean ± SEM)
during the memory reactivation trial in rats infused with vehicle or curcumin and later tested for
PR-STM. *p<0.05 relative to the pre-CS period. (h) Percent freezing (mean ± SEM) during the
PR-STM test in vehicle and curcumin groups. (i) Cannula placements for rats infused with either
vehicle (black circles) or curcumin (grey circles) and tested for PR-STM.
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Further, rats designated to be infused with either vehicle or curcumin exhibited significant and
equivalent memory recall during the reactivation session; the ANOVA (group by trial) revealed a
significant main effect of trial [pre-CS vs. CS; F (1,20) = 145.4, p < 0.01], but no significant main
effect of group [Vehicle vs. Curcumin; F (1,20) = 0.02724; Fig 3.2c]. The following day,
curcumin-treated rats exhibited significantly impaired PR-LTM compared to the vehicle group;
the repeated measures ANOVA (group by trial) revealed a significant main effect of trial [F (4,40)
= 8.528, p < 0.01], and a significant main effect of group [Vehicle vs. Curcumin; F (1,10) = 11.37,
p < 0.01] but no significant interaction [Group vs. Trial; F (4,40) = 1.45, p >0.05; Fig 3.2d].
Further, analysis of the first 3 trials of the PR-LTM test revealed significant group differences
[Vehicle vs. Curcumin; F (1,30) = 16.33, p < 0.01]. Cannula placements for both groups can be
found in Figure 3.2e.
In contrast to PR-LTM, intra-LA infusion of curcumin had no effect on PR-STM. All rats
exhibited equivalent post-shock freezing during training [Vehicle vs. Curcumin; F (1,12) = 0.71;
Fig 3.2f]. Further, vehicle- and curcumin-treated rats exhibited significant and equivalent
memory recall during the reactivation session; the ANOVA (group by trial) revealed a
significant main effect of trial [pre-CS vs. CS; F (1,24) = 86.78, p < 0.01], but no significant main
effect of group [Vehicle vs. Curcumin; F (1,24) = 0.036; Fig 3.2g]. Three hours after infusions,
both groups exhibited equivalent levels of freezing during the PR-STM test; the repeated
measures ANOVA (group by trial) revealed no main effect of trial [F (2,24) = 0.1587, p > 0.05],
no main effect of group [Vehicle vs. Curcumin; F (1,12) = 0.114, p > 0.05] and no significant
interaction [Group vs. Trial; F (3,36) = 0.52, p >0.05; Fig 3.2h]. This indicates that curcumin has
no effect on the retention of a fear memory when the animals are tested shortly after memory
reactivation and infusion. Cannula placements for both groups can be found in Figure 3.2i.
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Collectively, this pattern of findings (impaired PR-LTM, intact PR-STM) demonstrates that
intra-LA infusion of curcumin impaired the reconsolidation of a fear memory.
The reconsolidation deficit produced by curcumin is specific to a reactivated fear memory.
Importantly, in a separate experiment we observed that the reconsolidation disruption produced
by curcumin is specific to a reactivated fear memory. Rats were fear conditioned as before,
followed by a ‘no-reactivation’ session 24 hours later in which they were placed in the testing
context for an equivalent amount of time without a tone presentation. One hour following the
‘no-reactivation’ session, rats received intra-LA infusion of either vehicle or curcumin as before
followed by a ‘PR’-LTM test 24 hours later (Fig 3.3a). All rats exhibited equivalent post-shock
freezing during training [Vehicle vs. Curcumin; F (1,11) = 2.06; Fig 3.3f]. Further, rats designated
to be infused with either vehicle or curcumin following the no-reactivation session exhibited
equivalently low levels of freezing during the ‘pre-CS’ period and during the 30 sec period when
the tone would have normally been presented (Fig 3.3c). An ANOVA (group by trial) revealed
no significant effect of group [Vehicle vs. Curcumin; F (1,22) = 0.079, p > 0.05] or trial [F (1,22) =
1.053, p > 0.05]. Similarly, both vehicle and curcumin-treated rats exhibited no difference in
levels of freezing during the ‘PR’-LTM test; the ANOVA (group by trial) revealed a significant
main effect of trial [F(4,44) = 4.732, p < 0.05], but no significant main effect of group [Vehicle vs.
Curcumin; F (1,11) = 0.2865] or significant interaction [Group vs. Trial; F (4,44) = 0.74, p >0.05;
Fig 3.3d]. Cannula placements for both groups can be found in Figure 3.3e. This finding suggests
that curcumin is only effective at impairing the long-term expression of a fear memory if
administered around the time of active memory recall.
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Figure 3.3. The reconsolidation deficit induced by intra-LA curcumin infusion is dependent on
the retrieval of the fear memory and is constrained to a specific temporal window. (a) Schematic
of the behavioral protocol. Rats were treated identically to those in Figure 1 with the exception
that they were not exposed to a tone during the reactivation session (No Reactivation). All rats
were then tested 24 hrs later for PR-LTM. (b) Percent post-shock freezing (mean ± SEM) during
fear conditioning in rats infused with either vehicle (n = 7) or curcumin (n = 6) following the no
reactivation session. (c) Percent freezing (mean ± SEM) during the no reactivation session in rats
infused with vehicle or curcumin and later tested for PR-LTM. (d) Percent freezing (mean ±
SEM) during the PR-LTM test in vehicle and curcumin groups. (e) Cannula placements for rats
infused with either vehicle (black circles) or curcumin (grey circles) following the no
reactivation session and tested for PR-LTM. (f) Schematic of the behavioral protocol for the
delayed infusion experiment. Rats were treated identically to those in Figure 1 with the exception
that vehicle or curcumin infusion was given 6 hrs following memory reactivation. All rats were
then tested for PR-LTM. (g) Percent post-shock freezing (mean ± SEM) during fear conditioning
in rats infused with either vehicle (n = 7) or curcumin (n = 6) following the no reactivation
session. (h) Percent freezing (mean ± SEM) during the memory reactivation trial in rats infused
with vehicle or curcumin 6 hrs after reactivation and later tested for PR-LTM. *p<0.05 relative
to the pre-CS period. (i) Percent freezing (mean ± SEM) during the PR-LTM test in vehicle and
curcumin groups. (j) Cannula placements for rats infused with either vehicle (black circles) or
curcumin (grey circles) 6 hrs following reactivation and tested for PR-LTM.
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The reconsolidation deficit induced by curcumin is temporally specific. Finally, we
observed in a separate experiment that the effect of curcumin on fear memory reconsolidation is
temporally constrained; when rats were given intra-LA infusion of curcumin 6 hours following
memory reactivation (Fig 3.3f), there was no effect on PR-LTM. All rats exhibited equivalent
post-shock freezing during training [Vehicle vs. Curcumin; F (1,10) = 0.29; Fig 3.3g]. Further, rats
designated to be infused with either vehicle or curcumin exhibited significant and equivalent
memory recall during the reactivation session; the ANOVA (group by trial) revealed a
significant main effect of trial [pre-CS vs. CS; F (1,20) = 44, p < 0.01], but no significant main
effect of group [Vehicle vs. Curcumin; F (1,20) = 0.56; Fig 3.3h]. Finally, the ANOVA (group by
trial) for PR-LTM revealed a significant main effect of trial [pre-CS vs. CS; F (4,40) = 7.178, p <
0.05], but no significant main effect of group [Vehicle vs. Curcumin; F (1,10) = 1.086] or
significant interaction [Group vs. Trial; F (4,40) = 0.19, p >0.05; Fig 3.3i]. Thus, intra-LA infusion
of curcumin within a narrow window (1 hour) following fear memory retrieval significantly
impairs the reconsolidation of a fear memory.

Figure 3.4. Intra-LA infusion of curcumin impairs the reconsolidation of an older fear memory.
(a) Schematic of the behavioral protocol. Rats were fear conditioned with three 3-shock pairings
as in Figure 1. Two weeks following training rats were given a memory reactivation session
followed 1 hr later by intra-LA infusion of vehicle (n = 7) or curcumin (1 µg/side; n = 8). Rats
were then tested for PR-LTM 24 hrs later. (b) Percent post-shock freezing (mean ± SEM) during
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fear conditioning in rats infused with either vehicle or curcumin following reactivation. (c)
Percent freezing (mean ± SEM) during the memory reactivation trial in rats infused with vehicle
or curcumin. *p<0.05 relative to the pre-CS period. (d) Percent freezing (mean ± SEM) during
the PR-LTM test in vehicle and curcumin groups. (e) Cannula placements for rats infused with
either vehicle (black circles) or curcumin (grey circles).
Intra-LA infusion of curcumin impairs the reconsolidation of an older fear memory
In each of our previous experiments, we reactivated the fear memory within 24 hours following
training. We next asked whether curcumin could impair the reconsolidation of an older fear
memory. Rats were fear conditioned as before. Two weeks later, rats received a memory
reactivation trial followed by intra-LA infusion of either vehicle or curcumin (Fig 3.4a). Both
groups showed equivalent post-shock freezing during training [F (1,13) = 2.55; Fig 3.4b] and
equivalently high levels of freezing during the reactivation session (Fig 3.4c); an ANOVA
(group by trial) revealed a significant main effect of trial [pre-CS vs. CS; F (1,26) = 230.2, p <
0.01] but not of group [Vehicle vs. Curcumin; F (1,26) = 0.000827]. On the following day,
however, curcumin-treated rats exhibited impaired PR-LTM relative to the vehicle-infused
controls; the ANOVA (group by trial) revealed a significant main effect of trial [F (4,52) = 11.11,
p < 0.01], and a significant main effect of group [Vehicle vs. Curcumin; F (1,13) = 19.22], but no
significant interaction [Group vs. Trial; F (4,52) = 1.07, p >0.05; Figure 3.4d]. Further, analysis of
the first 3 trials of the PR-LTM test revealed significant group differences [Vehicle vs.
Curcumin; F (1,39) = 21.37, p < 0.01]. Thus, infusions of curcumin into the LA can effectively
impair the reconsolidation of both recently learned as well as older fear memories.
Discussion
Our initial experiments demonstrated that a dietary supplement of curcumin impaired the
reconsolidation of a Pavlovian fear memory (Monsey et al., 2015). In these second sets of
experiments, we systemically examined how curcumin impaired fear memory reconsolidation at
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the level of the LA. The experiments provide evidence that direct infusions of curcumin into the
LA impairs the reconsolidation of a Pavlovian fear memory. Specifically, infusion of curcumin
one hour after retrieval impairs IKK-α signaling, which subsequently impairs histone acetylation
and Egr-1 activation, all critical for the reconsolidation of a Pavlovian fear memory. Further,
infusions of curcumin one hour after retrieval behaviorally impaired the reconsolidation of a 1day and 2-week old fear memory, and this effect was dependent not only on the memory being
reactivated, but also being constrained to a specific time window.
Lubin & Sweatt (2007) discovered that the IKK:NF-kB signaling pathway is involved in
an intricate sequence of events during the reconsolidation process. Within the hippocampus, they
demonstrated that IKK-α phosphorylation is necessary for the reconsolidation of a contextual
fear memory. Further, they demonstrated that histone H3 acetylation and phosphorylation is
associated with activation of the IKK:NK-kB signaling pathway, and pinpointed histone H3
acetylation and phosphorylation to IKK-α activity. Finally, the authors showed that inhibition of
IKK-α impaired expression of the IEG Egr-1. Our results within the LA fall in line with what
Lubin and Sweatt (2007) discovered with the hippocampus in regard to the reconsolidation of a
Pavlovian fear memory. Therefore, our findings give further evidence that the IKK-α activity
plays a critical role in fear memory reconsolidation, and that local infusions of curcumin into the
LA not only impairs the activation of IKK-α, but the reconsolidation of a Pavlovian fear
memory.
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Chapter 4: Curcumin Enhances the Extinction of a Pavlovian Fear Memory
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For the final set of experiments, we explored whether dietary or infused curcumin had
any effect on the extinction of a Pavlovian fear memory. The finding that curcumin impaired the
consolidation and reconsolidation of a Pavlovian fear memory gave us an indication that
curcumin exerted a modulatory effect on Pavlovian fear memories. Further, evidence from Ch.2
and Ch. 3 showed that curcumin decreased levels of phosphorylated IKK-a and histone H3
acetylation after training and retrieval, respectively. This correlated with other findings showing
that a decrease in p300/CBP activity led to the enhancement of the extinction of a Pavlovian fear
memory (Wei et al., 2012) and a decrease in IKK:NF-kB inflammatory signaling activity (de la
Fuente et al., 2011). These two studies led us to hypothesize that a decrease in both histone H3
acetylation and IKK:NF-kB inflammatory signaling pathway activity leads to an enhancement of
an extinction memory. Therefore, we explored the effects of curcumin on fear memory
extinction and associated molecular signaling pathways by using both a dietary manipulation and
direct infusions of curcumin into the infralimbic cortex (IL).
Methods.
Subjects. Adult-male Sprague-Dawley rats (Harlan), weighing 300-350g and aged 2-3
months, were housed individually in plastic cages and maintained on a 12:12 hr light/dark cycle
with food and water provided ad libitum.
Curcumin Diet. Rats were given either a global 18% protein chow diet (Control chow;
Harlan Teklad) or a global 18% protein chow diet commercially made with 1.5% curcumin
(Curcumin chow; Fisher Scientific, 95% curcumin (diferuloylmethane)). This relatively high
concentration of curcumin was chosen because of the well-documented low bioavailability of the
compound (Gupta et al., 2012). Both diets were provided in pellet form and stored at 4 degrees C
until use. Rats were observed to eat, on average, 18g of curcumin or chow diet per day over a 564

day period (~270 mg curcumin/day, on average) that did not differ significantly between groups
(Control chow: ~ 30g; Curcumin show: ~ 30g, p>0.05; data not shown). Rats were observed to
tolerate the curcumin-enriched diet well, with no observable signs of distress and comparable
weight gain on day 5 of the diet relative to a group eating control chow (Control chow: ~ 30%
gain from day 1; Curcumin chow: ~ 30% gain from day 1, p>0.05).
Surgery. Rats were anesthetized with i.p. administration of ketamine (100 mg/kg) and
xylazine (6.0 mg/kg) and implanted with 33-gauge stainless-steel guide cannulas (Plastics One,
Roanoke, VA) into the IL (AP: +3.0 mm, ML: ±0.6 mm, DV: -4.6 mm relative to Bregma).
Guide cannulas were secured to screws in the skull using a mixture of dental acrylic and cement,
and dust caps were inserted onto the guide to prevent obstruction. Buprenex (0.2 mg/kg) was
administered as an analgesic and rats were provided with at least five days post-operative
recovery time. All surgical procedures were conducted under the guidelines provided in the
National Institutes of Health Guide for the Care and Use of Experimental Rats and were
approved by the Hunter College, CUNY Institutional Animal Care and Use Committee.
Drugs. Curcumin (Fisher Scientific, 95% curcumin (diferuloylmethane)) was dissolved in
100% DMSO to a 4 µg/µl stock solution and then diluted in ultrapure H2O to a final
concentration of 1µg/µl solution for infusion into the brain. Curcumin-treated rats received
bilateral intra-IL infusions of 1 µg curcumin in 0.5 µl. Vehicle-treated rats received bilateral
intra-IL infusions of an equal volume 50% DMSO in ultrapure H2O.
Pharmacology & Western blotting experiments. For Western blotting experiments
examining the effect of curcumin on extinction-related regulation of phosphorylated IKK,
histone acetylation, and EGR-1, cannulated rats were habituated to handling, the conditioning
chambers, and the testing chambers (30min/day/chamber) for 4 days prior to auditory fear
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conditioning. Fear conditioning consisted of 3 tone-shock pairings (30 sec, 5 kHz, 75 dB; 1.0
mA; ITI=2 mins). The conditioning chamber (Context A) was a lit chamber with a grid floor,
while the extinction chamber (Context B) consisted of a dark chamber (no lights) with a black
plastic floor, which was washed with a peppermint soap (Dr. Bronner’s Pure-Castile)
immediately before extinction training. Twenty-four hours after conditioning, rats were given an
auditory fear memory extinction session consisting of seven tones (30sec, 5kHz, 75 dB) which
was administered in Context B.
For the systemic curcumin experiments, rats were sacrificed 90 min after the end of the
extinction training session and brains were removed and frozen at -80ºC until processed.
Additional groups of “Naïve-Chow” and “Naïve-Curcumin” rats were handled and habituated
but not exposed to the training or testing chamber prior to being sacrificed on the same day. For
the infusion experiments, rats were infused with either curcumin (1 µg/side) or vehicle (0.5
µl/side) immediately after the extinction training session. Ninety min following infusions, rats
were sacrificed, and brains were removed and frozen at -80ºC until processed. An additional
group of “Naïve-Vehicle” rats were handled and habituated but not exposed to the training or
testing chamber prior to infusion of vehicle (0.5 µl/side) and were sacrificed 90 min following
infusions. The 90-min time point was chosen because it allowed us to successfully capture the
upregulation of our target molecular pathways based on previous findings (Lubin & Sweatt,
2007; Maddox & Schafe, 2011a; Maddox, Watts, & Schafe, 2013; Yeh et al., 2004).
Punches containing the IL were obtained with a 2-mm punch tool (Fine Science Tools,
Foster City, CA) from 400-µm-thick sections taken on a sliding freezing microtome. Punches
were manually dounced in 200 µl of ice-cold hypotonic lysis buffer [10 mM Tris-HCl, pH
7.5, 1 mM EDTA, 2.5 mM sodium pyrophosphate, 1 mM phenylmethylsulfonyl fluoride, 1 mM b66

glycerophosphate, 1% Igepal CA-630, 1% protease inhibitor cocktail (Sigma) and 1 mM sodium
orthovanadate]. Sample buffer was immediately added to the homogenates, and the samples were
boiled for 4 min. Homogenates were electrophoresed on 18% Tris-HCl gels and blotted to
Immobilon-P (Millipore, Bedford, MA). Western blots were then blocked in TTBS buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.05% Tween-20) with 5% dry milk and then
incubated with the appropriate primary antibody [anti-phospho-IKK alpha/beta, 1:2,000, Cell
Signaling; anti-IKK alpha (‘total IKK’), 1:2,000, Cell Signaling; anti-acetyl-H3 (pan), 1:3,000,
Millipore; anti-acetyl-H3Lys18, 1:1,000, Cell Signaling; anti-H3 (‘total H3’), 1:5,000, Millipore;
anti-Egr-1, 1:1,000, Santa Cruz]. Blots were then incubated with anti-rabbit antibody conjugated
to horseradish peroxidase (Cell Signaling, Danvers, MA) and developed using West Dura
chemiluminescent substrate (Pierce Laboratories, Rockford, IL). Western blots were developed in
the linear range used for densitometry. Densitometry was conducted using Image J software. To
control for inconsistencies in loading, optical densities for total IKK, total histone and Egr-1
proteins were normalized to GAPDH protein (1:20,000; Abcam). Acetyl-histone proteins were
normalized to total-histone protein and phosphoIKK-α proteins were normalized to total IKK-α
protein. Data were normalized to the average value of naïve controls and analyzed using
ANOVA.
Behavioral experiments. For the curcumin diet experiments, rats were handled for 2 days
prior to conditioning. Rats were habituated to Context A for 15 minutes (Day 1). The following
day (Day 2), rats were placed in Context A and presented with 3 tone-shock pairings consisting
of a 30 sec, 5 kHz, 75 dB tone that co-terminated with a 1 sec, 1.0 mA foot shock (ITI=2 min).
Rats were then placed on either a control chow or a 1.5% curcumin enriched diet for 5 days. On
day 6 of the experiment, rats were placed in Context B and exposed to an extinction training
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session that consisted of either 7 or 40 tone presentations. The following day, rats received an
extinction testing session (Day 7), which consisted of 10 tone presentations (30 sec, 5 kHz, 75
dB) and was conducted in Context B.
For the infusion experiments, rats were handled for 2 days prior to conditioning. On the
second handling day, dummy cannulas were removed to check for patency. Rats were then
habituated to Context A for 15 minutes (Day 1). The following day (Day 2), rats were placed in
Context A and presented with 3 tone-shock pairings consisting of a 30 sec, 5 kHz, 75 dB tone
that co-terminated with a 1 sec, 1.0 mA foot shock (ITI=2 min). The next day (Day 3), rats were
placed in Context B and exposed to an extinction training session that consisted of either 7 or 20
tone presentations. Immediately after extinction training, rats received intra-IL infusions of either
curcumin (1 µg/side) or vehicle (0.5 µl/side). Infusions were made over 4 mins and the infusion
cannulas were left in place for at least 2 min following infusion to facilitate diffusion throughout
the IL. The following day, rats received an extinction testing session (Day 4), which consisted of
10 tone presentations (30 sec, 5 kHz, 75 dB) and was conducted in Context B.
For both the diet and infusion experiments, rats were given a reinstatement trial seven
days after extinction training. The reinstatement trial consisted of a single US footshock
presentation in a completely new context (Context C) that consisted of a rectangular white
enclosure with a plastic cover and thicker grid floors. The following day, all groups were given a
reinstatement test, which consisted of 5 CS tone presentations in Context B.
Each behavioral test was video recorded for subsequent scoring by an observer who was
blind to the experimental conditions. Freezing was defined as a lack of movement, excluding that
necessary for respiration, and was quantified as a percentage of the amount of time the rat spent
engaged in freezing behavior during the CS presentations. All data were analyzed with ANOVA
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and Tukey’s post-hoc t-tests. Repeated measures ANOVAs were used for multiple trial
comparisons. Differences were considered significant if p <0.05. For the infusion experiments,
only data from those rats with bilaterally well-placed cannulas within the borders of the IL were
included in the analyses.
Results.
Dietary curcumin impairs the phosphorylation of IkB kinase, but upregulates EGR-1 and
Arc expression, in the IL
In our first series of experiments, we asked whether a diet enriched with curcumin would
impair extinction training-related regulation of IkB kinase. Rats were fear conditioned with three
pairings of a tone (conditioned stimulus; CS) that co-terminated with a footshock (unconditioned
stimulus; US). Twenty-four hours following fear memory acquisition, rats were given a memory
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Figure 4.1 – Dietary curcumin impairs extinction training-related phosphorylation of IKK-α but
upregulates the expression of Arc and Egr-1. (a) Schematic of the behavioral protocol. Rats
were fear conditioned with 3 tone-shock pairings, followed by a memory test 24 hours later. On
day 4, rats were put on either a curcumin-enriched (n = 6) or chow (n = 6) diet for 5 days.
Another pair of (Naïve) groups (n = 6 each) did not receive conditioning nor extinction training
and were given either a curcumin-enriched or chow diet. Rats were sacrificed 90 min after
extinction training on day 10. (b) Percent freezing (mean ± SEM) during the conditioning trial
in rats. *p<0.05 relative to the pre-CS period. (c) Percent freezing (mean ± SEM) during the
extinction training trial in rats given either curcumin or chow for 5 days. *p<0.05 relative to the
pre-CS period. (d) Western blot analysis (mean ± SEM) of phosphorylated and total (nonphosphorylated) IKK-α from IL homogenates from Naïve-Chow (Naïve-Chow), ExtinctionChow (Ext-Chow), Naive-Curcumin (Naive-Curc), and Extinction-Curcumin (Ext-Curc) groups.
Levels of total IKK-α were first normalized to GAPDH. Levels of phospho-IKK-α were then
normalized to total IKK-α and expressed as a percentage of the Naïve-Chow group. * p < 0.05
relative to Ext-Chow. (e) Western blot analysis (mean ± SEM) of Egr-1 and Arc from IL
homogenates from Naïve-Chow, Ext-Chow, Naïve-Curc, and Ext-Curc groups. Levels of Egr-1
and Arc were normalized to GAPDH and expressed as a percentage of the Naïve-Chow group. *
p < 0.05 relative to Ext-Chow group.
test in Context B, which consisted of 1 CS presentation, in order to control for rats that did not
form a fear memory. Rats were then placed on either a curcumin or chow diet for five days. On
the sixth day of the diet, rats received an extinction training session that consisted of 7 CS
presentations in Context B. Rats were then sacrificed 90 min after the extinction training session
(Fig 4.1a). This time point was chosen based on previous observations that the molecular
proteins of interest peak at this time point in the LA (Monsey, Ota, Akingbade, Hong, & Schafe,
2011).
All rats exhibited equivalent post-shock freezing during fear memory acquisition [Chow
vs. Curcumin; F (1,10) = 1.56, p > 0.05; Figure 4.1b] and equivalent freezing during the memory
test [Chow vs. Curcumin; F (1,10) = 0.18, p > 0.05; data not shown]. Further, there was no
significant difference between the curcumin and chow groups during extinction training [Chow
vs. Curcumin; F (1,10) = 0.55, p > 0.05; Figure 4.1c]. Extinction of the fear memory led to a
significant decrease in IKK-α phosphorylation levels in the IL relative to Naive controls and was
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significantly decreased in the curcumin group [F (3,24) = 3.42, p < 0.05; Fig 4.1d]. Tukey’s posthoc t-tests revealed that the chow-naive group was not significantly different from curcuminnaive group (p > 0.05) or the chow-extinction group (p > 0.05). Further, the curcumin-extinction
group was significantly different from the other three groups (p < 0.05). Moreover, no difference
was observed between all three groups in total (non-phosphorylated) protein levels of IKK-α [F
(3,24) =

0.34; Fig 4.2d]. Finally, no difference was observed between all three groups in the

expression of GAPDH [F (3,24) = 0.21; data not shown], which was used as a loading control in
this and all subsequent Western blotting experiments.
We next examined the effects of dietary curcumin on training-related histone H3
acetylation in the IL. In these experiments, we probed our blots with both a ‘pan’ acetyl-H3
antibody and an antibody that specifically recognizes acetylation of histone H3 at lysine residue
18 (H3K18). Extinction of the fear memory led to no significant difference in overall H3
acetylation [F (3,28) = 0.45, p > 0.05; data not shown] and H3K18 acetylation [F (3,28) = 0.55, p <
0.05; data not shown] in the IL in the chow and curcumin groups, relative to the naive control
groups. Moreover, no difference was observed in total protein levels of histone H3 [F (3,28) =
0.09; data not shown].
Finally, we examined the impact of dietary curcumin on Egr-1 and Arc expression in the
IL. Extinction of the fear memory led to an increase in Egr-1 expression in the IL in the
curcumin-extinction group relative to the extinction-chow and naive controls [F (3,20) = 5.85, p <
0.05; Fig 4.1e)]. Tukey’s post-hoc t-tests revealed that the chow-naive group was not
significantly different from curcumin-naive group (p > 0.05) or the chow-extinction group
(p>0.05). Further, the curcumin-extinction group was not significantly different from the other
three groups (p < 0.05). Extinction of the fear memory also led to a significant increase in Arc
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expression in the IL relative to Naive controls that was enhanced by dietary curcumin [F (3,20) =
5.61, p < 0.05; Fig 4.2e). Tukey’s post-hoc t-tests revealed that the chow-naive group was not
significantly different from curcumin-naive group (p > 0.05) or the chow-extinction group
(p>0.05). Further, the curcumin-extinction group was significantly different from the other three
groups (p < 0.05).
Thus, extinction of an auditory fear memory leads to a significant decrease of IkB kinase
expression in the IL. Further, the training-related regulation of each of these molecular signaling
cascades is significantly affected by dietary curcumin.
Dietary curcumin facilitates the retention, and enhances the extinction, of a Pavlovian fear
memory
Based on the findings from the first experiment, we then asked whether dietary curcumin
had any behavioral effect on the extinction of an auditory Pavlovian fear memory. Rats were fear
conditioned with 3 pairings of a tone CS with footshock (see Methods) [F = .041, p>.05, Figure
4.2b]. All rats then received a memory test 24 hours after conditioning. We found no differences
between rats [t (15) = 1.11, p>.05, Figure 4.2c], and subjects were then placed into a curcumin diet
or chow diet group. Both groups were counterbalanced based on freezing % from the memory
test.
After a 5-day diet of curcumin or regular chow, rats were placed in Context B and given a
40-tone CS extinction training protocol. To our surprise, the curcumin diet group had a
significantly lower percentage of freezing, compared to the chow diet group, as the extinction
training session went on. Analysis of the extinction training session data revealed that the
curcumin diet rats exhibited a significantly lower percentage of freezing; the ANOVA (group by
trial) revealed a significant effect of trial [F (39,1092) = 18.44, p < 0.01], and of group [F (1,28) =
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18.48, p<0.01; Figure 4.2d]. Further, if we divide the extinction training session into separate 5
CS bins (for a total of 8 separate bins), we found that dietary curcumin had no effect on the
initial first CS presentations [Trials 1-5, t(30) = 1.44, p>.05] but significantly lowered freezing
percentage on subsequent trials, [trials 6-10, t (30) = 2.64, p < 0.05; trials 16-20, t(30) = 3.63,
p<.01; trials 21-25, t(30) = 2.13, p<.05; trials 26-30, t(30) = 3.22, p<.01; trials 31-35, t(30) = 5.45,
p<01; trials 36-40, t(30) = 3.56, p<.01, Figure 4.3d] compared to the chow diet group. Thus, a
curcumin-enriched diet initially had no effect on extinction training, but significantly lowered the
freezing percentage of subjects as the session went on, compared to the chow diet group.

Figure 4.2 – Dietary curcumin enhances fear memory extinction. (a) Schematic of the
behavioral protocol. Rats were fear conditioned, given a memory test, and began a diet of either
curcumin-enriched or regular chow. Both groups of rats then underwent extinction training and
extinction testing session. Seven days after the extinction testing session, rats underwent a
reinstatement trial, followed by a reinstatement test (day 19) and a renewal test (day 20). (b)
Percent post-shock freezing (mean ± SEM) during fear conditioning in rats given either regular
chow (n = 19) or curcumin (n = 15). (c) Percent freezing (mean ± SEM) during the memory test
trial. *p<0.05 relative to the pre-CS period. (d) Percent freezing (mean ± SEM) during the
extinction training session in rats given either regular chow and curcumin-enriched chow (e)
Percent freezing (mean ± SEM) during the extinction retention test for both groups. (f) Percent
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freezing (mean ± SEM) during the reinstatement test in both groups.. (g) Percent freezing (mean
± SEM) during the renewal test in both groups.

Importantly, we found that the effect of dietary curcumin transferred to the retention-testing day.
Twenty-four hours after extinction training, rats were placed in the Context B and were given 9
CS presentations. Analysis of the extinction retention session data revealed that the curcumin
diet group displayed significantly lower levels of freezing compared to the chow diet group
(Figure 4.2e). An ANOVA (group by trial) revealed a significant effect of trial [F (9,243) = 14.11,
p<.01] and group [F (1,27) = 19.5, p<.01]. Interestingly, when we separated the extinction
retention test into three separate bins, we found that dietary curcumin significantly lowered
freezing percentage, compared to the chow group, during trials 1-3 [t (30) = 4.05, p < 0.01] and
trials 4-6 [t (30) = 3.11, p < 0.01, Figure 4.3e]. Thus, a curcumin-enriched diet not only facilitated
the acquisition of an extinction memory, but also enhanced the retention of an extinction
memory, compared to the chow-diet group.
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Figure 4.3 – Dietary curcumin enhances fear memory extinction (Grouped Analysis). (a)
Schematic of the behavioral protocol. Rats were fear conditioned, given a memory test, and
began a diet of either curcumin-enriched or regular chow. Both groups of rats then underwent
extinction training and extinction testing session. Seven days after the extinction testing session,
rats underwent a reinstatement trial, followed by a reinstatement test (day 19) and a renewal test
(day 20). (b) Percent post-shock freezing (mean ± SEM) during fear conditioning in rats given
either regular chow (n = 19) or curcumin (n = 15). (c) Percent freezing (mean ± SEM) during the
memory test trial. *p<0.05 relative to the pre-CS period. (d) Bar graphs representing average
freezing during the extinction training trials in bins of 5 trials. *p<0.05 relative to the pre-CS
period. (e) Bar graphs representing average freezing during the extinction retention trials in bins
of 3 trials. *p<0.05 relative to the pre-CS period. (f) Bar graph representing the average freezing
during the reinstatement trial. *p<0.05 relative to the pre-CS period. (g) Bar graph representing
the average freezing during the renewal test. *p<0.05 relative to the pre-CS period.
Further, seven days after the extinction retention test, we gave both groups a
reinstatement trial, which consisted of a 1 US presentation in Context C (See Methods). The
following day, subjects were given a reinstatement test which consisted of 5 CS presentations in
Context B. Analysis of the reinstatement session data revealed that the curcumin diet group
displayed significantly lower levels of freezing compared to the chow diet group (Figure 4.2f).
An ANOVA (group by trial) revealed a significant effect of trial [F (4,112) = 20.27, p<.01] and
group [F(1,28) = 4.82, p<.05]. When we averaged the freezing percentage from both groups, we
found that the dietary curcumin group had a significantly lowered freezing percentage compared
to the chow group [t (30) = 2.31, p < 0.05, Figure 4.3f]. Twenty-four hours later, subjects were
given a renewal test, which consisted of 5 CS presentations in Context D (See Methods).
Analysis of the renewal session data revealed that the curcumin diet group displayed
significantly lower levels of freezing compared to the chow diet group (Figure 4.2g). An
ANOVA (group by trial) revealed a significant effect of trial [F (4,112) = 10.08, p<.01] and group
[F(1,28) = 5.16, p<.05]. When we averaged the freezing percentage from both groups, we found
that the dietary curcumin group had a significantly lowered freezing percentage compared to the
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chow group [t (30) = 2.75, p < 0.01, Figure 4.3g]. Thus, a curcumin-enriched diet impaired the
reinstatement and renewal of a Pavlovian fear memory.
Dietary curcumin enhances the retention of a partial extinction of a Pavlovian fear memory
Next, we asked whether dietary curcumin would enhance the retention of a partial
extinction memory. Since we saw that both groups had no difference in freezing percentage at
the start of extinction training in the first experiment, we decided to give a sub-optimal extinction
training session consisting of 7 CS presentations. Rats were fear conditioned as before [F (1,18) =
0.04, p > .05; Figure 4.4b] followed by a memory test twenty-four hours later [t (18) = 0.26, p >
.05, Figure 4.4c]. Rats were counter balanced and were given a five-day enriched diet of
curcumin or regular chow. On the sixth day of the diet, both groups were given an extinction
training session consisting of 7 CS presentations. Both group of rats exhibited similar levels of
freezing percentage during the extinction training session; the ANOVA (group by trial) revealed
a significant main effect of trial [F (6,108) = 7.27, p < .05], but no significant main effect of group
[F (1,18) = 0.001, p > .05; Figure 4.4d], indicating that a diet of curcumin had no effect on the
acquisition of an extinction fear memory when the session consisted of 7 CS presentations.
However, the following day, curcumin-fed rats exhibited enhanced extinction memory retention
compared to the chow group. An ANOVA analysis showed that the curcumin group had a
significantly lower percentage of freezing, overall, compared to the chow group [F (1,18) = 6.90, p
< 0.05; Figure 4.4e]. Interestingly, this effect began during the fourth CS presentation in the
extinction retention session, therefore we decided to analyze freezing percentage in 3 separate
bins consisting of three CS presentations. We found no significant difference during the onset of
the extinction retention session [t (18) = 1.43; p >.05], but found a significant difference between
the curcumin and chow diet groups during the middle [t(18) = 3.83 ; p<.05] and end [t(18) = 2.15 ;
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p<.05] of the session (Figure 4.4f). Therefore, curcumin enhances the retention of an extinction
memory during the course of the retention session.

Figure 4.4 – Dietary curcumin enhances the partial extinction of a fear memory. (a) Schematic
of the behavioral protocol. Rats were fear conditioned, given a memory test, and fed a 5-day diet
of either curcumin-enriched or regular chow diet. Rats were then given an extinction training
test, extinction retention test, reinstatement trial, and reinstatement test similar to Figure 4.2 (b)
Percent post-shock freezing (mean ± SEM) during fear conditioning in rats given either regular
chow (n = 8) or a curcumin-enriched diet (n = 8). (c) Percent freezing (mean ± SEM) during the
memory test trial in both groups. *p<0.05 relative to the pre-CS period. (d) Percent freezing
(mean ± SEM) during the extinction training trials in both groups. (e) Percent freezing (mean ±
SEM) during the extinction testing trials in both groups. (f) Bar graphs representing average
freezing during the extinction retention trials in bins of 3 trials. *p<0.05 relative to the pre-CS
period. (g) Percent freezing (mean ± SEM) during the reinstatement test both groups.
Infusion of curcumin impairs phosphorylation of IkB kinase, but upregulates Arc and Egr1 expression in the IL during consolidation of a fear memory
Based on our dietary findings, we wanted to see if the effects of curcumin could be
localized to the IL. Therefore, in our first series of localized infusion experiments, we asked
whether intra-IL infusion of curcumin would impair training-related regulation of IkB kinase.
Rats were fear conditioned with three pairings of a tone (conditioned stimulus; CS) that co77

terminated with a footshock (unconditioned stimulus; US). Twenty-four hours following fear
memory acquisition, rats received an extinction training session that consisted of 20 CS
presentations in Context B. Immediately after the extinction session, rats received an intra-IL
infusion of either vehicle (0.5 µl/side) or curcumin (1 µg/side; 0.5 µl) and were then sacrificed 45
min later (Fig 4.5a).

Figure 4.5 – Intra-IL infusion of curcumin enhances fear memory extinction training-related
expression of Egr-1 and Arc. (a) Schematic of the behavioral protocol. Rats were fear
conditioned with 3 tone-shock pairings. The following day, rats underwent an extinction training
session and received intra-IL infusion of either vehicle (n = 6) or curcumin (1 µg/side; n = 6)
immediately after the training session and were sacrificed 45 min later. A third (Naïve) group (n
= 6) did not receive conditioning and was infused with vehicle 30 mins prior to sacrifice. (b)
Percent post-shock freezing (mean ± SEM) during fear conditioning in rats. (c) Percent freezing
(mean ± SEM) during the extinction training session in rats prior to intra-IL infusion of vehicle
or curcumin. (d) Western blot analysis (mean ± SEM) of Egr-1 and Arc from IL homogenates
from Naïve-Veh, Ext-Veh and Ext-Curc groups. Levels of Egr-1 and Arc were normalized to
GAPDH and expressed as a percentage of the Naïve-Veh group. * p < 0.05 relative to Ext-Veh
group. (e) Western blot analysis (mean ± SEM) of acetylated histone H3 (Pan), acetylated H3Lysine 18, and total (non-acetylated) H3 from IL homogenates from Naïve-Veh, Ext-Veh and
Ext-Curc groups. Levels of total H3 were first normalized to GAPDH. Levels of acetyl-H3
(pan) and acetyl-H3-Lys18 were then normalized to total H3 and expressed as a percentage of
the Naïve-Veh group. * p < 0.05 relative to Ext-Veh group. (f) Western blot analysis (mean ±
SEM) of phosphorylated and total (non-phosphorylated) IKK-α from IL homogenates from
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Naïve-Veh, Ext-Veh, and Ext-Curc groups. Levels of total IKK-α were first normalized to
GAPDH. Levels of phospho-IKK-α were then normalized to total IKK-α and expressed as a
percentage of the Naïve-Veh group. * p < 0.05 relative to Ext-Veh. (g) Representative Western
blots for each experiment.
All rats exhibited equivalent post-shock freezing during fear memory acquisition [Vehicle vs.
Curcumin; F (1,14) = 0.01, p > 0.05; Figure 4.5b]. Further, there was no significant difference
during extinction training [Vehicle vs. Curcumin; F (1,14) = 0.34, p > 0.05; Figure 4.5c].
Extinction of the fear memory led to no significant differences in IKK-α phosphorylation in the
IL relative to Naive controls [F (2,15) = 0.35, p > 0.05; Fig 4.5d). Moreover, no difference was
observed in total (non-phosphorylated) protein levels of IKK-α [F (2,15) = 1.50; Fig 4.5d]. Finally,
no difference was observed in the expression of GAPDH [F (2,15) = 0 .21; data not shown], which
was used as a loading control in this and all subsequent Western blotting experiments.
We next examined the effects of intra-IL infusion of curcumin on training-related histone
H3 acetylation in the IL. In these experiments, we probed our blots with both a ‘pan’ acetyl-H3
antibody and an antibody that specifically recognizes acetylation of histone H3 at lysine residue
18 (H3K18). Extinction of the fear memory led to no significant differences in overall H3
acetylation [F (2,20) = 0.03, p > 0.05; Fig 4.5e] and H3K18 acetylation [F (2,20) = 0.11, p > 0.05;
Fig 4.5e] in the IL relative to Naive controls. Moreover, no difference was observed in total
protein levels of histone H3 [F (2,20) = 0.89; Figure 4.5e].
Finally, we examined the impact of intra-IL infusion of curcumin on Arc and Egr-1
expression in the IL. Extinction of the fear memory led to a significant increase in Arc
expression in the IL relative to Naive controls that was enhanced by intra-IL infusion of
curcumin [F (2,16) = 5.40, p < 0.05; Fig 4.5f)]. Tukey’s post-hoc t-tests revealed that the trainingvehicle group was not significantly different from naïve-vehicle controls (p > 0.05). Further, the
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training-curcumin group was significantly different from the training-vehicle group (p < 0.05),
and the naïve-vehicle group (p < 0.05).
Further, extinction of the fear memory led to a significant increase in Egr-1 expression in
the IL relative to Naive controls that was enhanced by intra-IL infusion of curcumin [F (2,16) =
9.03, p < 0.05; Fig 4.5f)]. Tukey’s post-hoc t-tests revealed that the training-vehicle group was
not significantly different from naïve-vehicle controls (p > 0.05). Further, the training-curcumin
group was significantly different from the training-vehicle group (p < 0.05), and the naïvevehicle group (p < 0.05).
Thus, extinction of an auditory fear memory leads to significant regulation of IEG
expression in the IL. Further, the training-related regulation of each of both Egr-1 and Arc is
significantly facilitated by intra-IL infusion of curcumin.
Intra-IL infusion of curcumin facilitates fear memory extinction
We next examined the effect of intra-IL infusion of curcumin on fear memory extinction.
Rats were trained and infused as in our Western blot experiments (above) and were then given an
extinction training session consisting of 20 CS presentations ~24 hrs after conditioning. Separate
groups of rats were trained, infused, and given an extinction training session consisting of 7 CS
presentations ~24 hours after conditioning (Fig 4.6a). For the 20 CS group, all rats exhibited
equivalent post-shock freezing during training [Vehicle vs. Curcumin; F (1,13) = 0.01; Fig 4.6b].
The following day, curcumin-infused rats and vehicle-infused rats exhibited similar extinction
training curves [Vehicle vs. Curcumin; F (1,13) = 0.09; Fig 4.6c]. Twenty-four hours later, the
curcumin-infused group exhibited a significantly lower percentage of freezing during the
extinction retention test compared to the vehicle group; the repeated measures ANOVA (group
by trial) revealed a significant main effect of trial [F (4,52) = 15.66, p < 0.01], and a significant
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main effect of group [Vehicle vs. Curcumin; F (1,13) = 8.17, p < 0.05; Fig 4.6d]. Seven days after
the extinction retention test, both groups were given a reinstatement trial, where 1 US reminder
shock was delivered. Twenty-four hours later, both groups underwent a reinstatement test, in
which 5 CS tones were presented in Context B. The curcumin-infused group exhibited a
significantly lower percentage of freezing during the reinstatement test compared to the vehicle
group; the repeated measures ANOVA (group by trial) revealed a significant main effect of trial
[F (4,48) = 18.84, p < 0.01], and a significant main effect of group [Vehicle vs. Curcumin; F (1,13) =
29.41, p < 0.01; Fig 4.6e]. Cannula placements for both groups can be found in Figure 4.6f.

Figure 4.6 – Intra-IL infusion of curcumin enhances fear memory extinction. (a) Schematic of
the behavioral protocol. Rats were fear conditioned, extinguished, and infused with either
vehicle or curcumin as in Figure 4.5. They subsequently underwent extinction retention testing, a
reinstatement trial, and a reinstatement test. (b) Percent post-shock freezing (mean ± SEM)
during fear conditioning in rats infused with either vehicle (n = 8) or curcumin (n = 8) following
extinction training and later tested for extinction retention. (c) Percent freezing (mean ± SEM)
during the extinction training session in rats infused with vehicle or curcumin and later tested for
extinction retention. *p<0.05 relative to the pre-CS period. (d) Percent freezing (mean ± SEM)
during the extinction retention test in vehicle and curcumin groups. (e) Percent freezing (mean ±
SEM) during the reinstatement test in rats infused with vehicle or curcumin (f) Cannula
placements for rats infused with either vehicle (white circles) or curcumin (orange circles).
81

In contrast to 20 CS group, intra-IL infusion of curcumin had no effect on extinction
retention with a 7 CS extinction training protocol. All rats exhibited equivalent post-shock
freezing during training [Vehicle vs. Curcumin; F (1,15) = 0.17; Fig 4.7b]. Twenty-four hours after
conditioning, both groups exhibited equivalent levels of freezing during extinction training with
7 CS presentations; the repeated measures ANOVA (group by trial) revealed a main effect of
trial [F (6,90) = 4.59, p < 0.05], but no main effect of group [Vehicle vs. Curcumin; F (1,15) = 0.15,
p > 0.05] and no significant interaction [Group vs. Trial; F (6,90) = 1.35, p > 0.05; Fig 4.7c].
Twenty-four hours after training, both groups exhibited equivalent levels of freezing during
extinction testing; the repeated measures ANOVA (group by trial) revealed a main effect of trial
[F (9,135) = 10.79, p < 0.05], but no main effect of group [Vehicle vs. Curcumin; F (1,15) = 0.81, p >
0.05] and no significant interaction [Group vs. Trial; F (9,135) = 0.49, p > 0.05; Fig 4.7d]. This
indicates that curcumin facilitates extinction consolidation with a 20 CS extinction training
protocol but not with a 7 CS extinction training protocol. Seven days after the extinction
retention test, both groups were given a reinstatement trial, where 1 US reminder shock was
delivered. Twenty-four hours later, both groups underwent a reinstatement test, in which 5 CS
tones were presented in Context B. The curcumin-infused group exhibited a significantly lower
percentage of freezing during the reinstatement test compared to the vehicle group; the repeated
measures ANOVA (group by trial) revealed a significant main effect of trial [F (4,48) = 18.31, p <
0.01], and a significant main effect of group [Vehicle vs. Curcumin; F (1,13) = 9.25, p < 0.01; Fig
4.7e]. Cannula placements for both experiments can be found in Figure 4.7f. Collectively, this
pattern of findings suggests that intra-IL infusion of curcumin facilitates the extinction of a fear
memory with more substantial presentations of the CS.

82

Figure 4.7 – Intra-IL infusion of curcumin has no effect on partial fear memory extinction. (a)
Schematic of the behavioral protocol. Rats were fear conditioned, extinguished, and infused
with either vehicle or curcumin as in Figure 4.6. They subsequently underwent extinction
retention testing, a reinstatement trial, and a reinstatement test. (b) Percent post-shock freezing
(mean ± SEM) during fear conditioning in rats infused with either vehicle (n = 8) or curcumin (n
= 8) following extinction training and later tested for extinction retention. (c) Percent freezing
(mean ± SEM) during the extinction training session in rats infused with vehicle or curcumin and
later tested for extinction retention. *p<0.05 relative to the pre-CS period. (d) Percent freezing
(mean ± SEM) during the extinction retention test in vehicle and curcumin groups. (e) Percent
freezing (mean ± SEM) during the reinstatement test in rats infused with vehicle or curcumin (f)
Cannula placements for rats infused with either vehicle (white circles) or curcumin (orange
circles).
Intra-IL infusion of curcumin immediately before extinction training has no effect on the
extinction of a fear memory
In each of our previous experiments, we infused curcumin immediately after extinction
training. We next asked whether infusion of curcumin into the IL, immediately before extinction
training, would affect the acquisition of an extinction memory. Rats were fear conditioned as
before, and twenty-four hours later received an intra-IL infusion of vehicle or curcumin
immediately before extinction training (Fig 4.8a). Both groups showed equivalent post-shock
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freezing during training [F (1,11) = 0.73, p > .05; Fig 4.8b]. On the following day, there was no
significant difference between the curcumin and vehicle treated groups during the extinction
training session; the ANOVA (group by trial) revealed a main effect of trial [F (19,209) = 38.51, p
< 0.05], and no significant main effect of group [Vehicle vs. Curcumin; F (1,11) = 0.87, p > 0.05],

Figure 4.8 – Intra-IL infusion of curcumin has no effect on extinction acquisition. (a) Schematic
of the behavioral protocol. Rats were fear conditioned and extinguished as in Figure 4.6,
however, they were infused with either vehicle or curcumin immediately before extinction
training. They subsequently underwent extinction retention testing. (b) Percent post-shock
freezing (mean ± SEM) during fear conditioning in rats infused with either vehicle (n = 8) or
curcumin (n = 8) following extinction training and later tested for extinction retention. (c)
Percent freezing (mean ± SEM) during the extinction training session in rats infused with vehicle
or curcumin and later tested for extinction retention. (d) Percent freezing (mean ± SEM) during
the extinction retention test in vehicle and curcumin groups. (e) Cannula placements for rats
infused with either vehicle (white circles) or curcumin (orange circles).
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and no significant interaction [Group vs. Trial; F (19,209) = 0.56, p > 0.05; Figure 4.8c]. Further,
there was no difference between the curcumin and vehicle treated group during extinction
retention testing; the ANOVA (group by trial) revealed a main effect of trial [F (4,44) = 9.49, p <
0.05], and no significant main effect of group [Vehicle vs. Curcumin; F (1,11) = 1.17, p > 0.05],
and no significant interaction [Group vs. Trial; F (4,44) = 0.23, p > 0.05; Figure 4.8d]. Thus, an
infusion of curcumin into the IL immediately before extinction training does not significantly
facilitate the acquisition or consolidation of an extinction memory.
Discussion
In these last set of experiments, we sought to examine the role of dietary and infused
curcumin on the extinction of a Pavlovian fear memory. We demonstrate that a 5-day diet of
curcumin leads to a significant downregulation of phosphorylated IKK-a, had no effect on the
acetylation of histones, and significantly upregulated expression of Arc and Egr-1, in the IL after
a 7 CS extinction training session. Further, we show that a 5-day diet of curcumin enhances the
acquisition and retention of an extinction memory with a 40 CS extinction session, and the
retention of an extinction memory with a 7 CS extinction training session.
Our infusion experiments show that direct intra-IL infusions of curcumin significantly
upregulates the expression of IEGs within the IL 45 min after extinction training. Further, local
infusions of curcumin into the IL facilitates the retention of an extinction memory with a 20-CS
extinction training protocol. Finally, intra-IL infusions of curcumin do not affect the acquisition
of an extinction memory. Our findings represent the first look at the role of curcumin in ILdependent learning and memory and associated behavior.
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Chapter 5: General Discussion
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Overall Summary
There has been considerable progress in describing the biological mechanisms in which
fear memories are formed, and how they can be subsequently modulated, using pharmacological
tools. Much of this research has aspired to discover pharmacological compounds that could be
used as a treatment option for psychiatric disorders characterized by intense fear and trauma.
However, few compounds have emerged that can be both effective and safe for clinical use. The
present dissertation provides preclinical evidence for curcumin as a possible pharmacological
tool that can be used in conjunction with existing behavioral treatment for patients.
In Chapter 2, our lab investigated the role of curcumin in amygdala-dependent auditory
Pavlovian fear memory consolidation and associated molecular events. We first demonstrated
that curcumin impairs training related upregulation of phosphorylated IKK-a, histone H3
acetylation, histone H3 acetylation at the specific lysine residue 18, and of the immediate early
gene Egr-1. Next, we showed that direct intra-LA infusion of curcumin had no effect on STM,
but impaired LTM, and that this effect was temporally constrained. Finally, we showed that at a
lower dose, curcumin had a relatively small effect on LTM that trended towards significance.
Overall, the findings in Chapter 2 clearly suggest that curcumin impairs fear memory formation
at the level of the lateral amygdala.
Considering the findings in Chapter 2, and of our previous dietary experiments (Monsey
et al., 2015), we sought to find the effect of intra-LA infusion of curcumin on the reconsolidation
of a fear memory. We first show that curcumin impairs retrieval related upregulation of
phosphorylated IKK-a, histone H3 acetylation, histone H3 acetylation at the specific lysine
residue 18, and of the immediate early gene Egr-1. Next, we demonstrated that direct intra-LA
infusion of curcumin had no effect on PR-STM, but impaired PR-LTM. This effect was shown to
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be temporally constrained, and dependent on the fear memory being reactivated. Finally, and
more clinically relevant, we showed that curcumin impaired PR-LTM of a 2-week-old fear
memory. The findings in Chapter 3 demonstrate that curcumin impairs fear memory
reconsolidation at the level of the lateral amygdala.
Given that our previous findings demonstrated curcumin’s potential at impairing the
consolidation and reconsolidation of an auditory Pavlovian fear memory, our next step was to
investigate the effect of curcumin on the extinction of a Pavlovian fear memory. Contrary to our
previous findings within the LA, we showed that a five-day diet of curcumin (1.5%) significantly
upregulated the immediate early genes Arc and Egr-1 within the IL. Further, we showed that a
diet of curcumin, much like our previous findings, significantly impaired the activation of
phosphorylated IKK- a. Behaviorally, and of clinical importance, we demonstrated that a 5-day
diet of curcumin enhanced the acquisition and retention of a 40 CS extinction memory, and that
the curcumin group was resistant to reinstatement and renewal. Further, a 5-day diet of curcumin
enhanced the retention of a 7 CS extinction training session.
In light of these findings, we sought to investigate a systematic analysis of curcumin’s
effect at the level of the infralimbic cortex. We showed that intra-IL infusions of curcumin
significantly upregulated the immediate early genes Arc and Egr-1 after a 20 CS extinction
session. Behaviorally, intra-IL infusions of curcumin enhanced the retention of a 20 CS
extinction training session, and the curcumin group was resistant to reinstatement and renewal.
Further, we found no effect of intra-IL infusions of curcumin on the acquisition of an extinction
memory, or on the retention of a 7 CS extinction training session. Interestingly, intra-IL
infusions of curcumin immediately before a 20 CS extinction training session significantly
impaired freezing percentages during the first two trials of training but had no effect during the
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subsequent trials nor on the retention of the extinction session. Collectively, Chapter 4 indicates
that dietary curcumin enhances the acquisition and retention of a Pavlovian auditory extinction
memory. Further, this effect can be pinpointed to the infralimbic cortex, and specifically to the
retention of the extinction memory.
These results are interesting given that our lab has recently focused on the role of
chromatin modifying enzymes in the fear memory consolidation and reconsolidation process. We
have shown that the formation and reconsolidation of a Pavlovian fear memory is associated with
an increase in histone H3 acetylation in the LA (Maddox & Schafe, 2011a), and that intra-LA
infusion of an HDAC inhibitor enhances the consolidation of an auditory fear memory (Maddox
& Schafe, 2011a). Further, our lab has shown that intra-LA infusion of the p300/CBP HAT
inhibitor c646 impairs training- and retrieval-related regulation of histone H3 acetylation in the
LA (Maddox et al., 2013). Intra-LA infusion of c646 following auditory fear memory
conditioning was observed to significantly interfere with the consolidation and reconsolidation of
a Pavlovian fear memory. Importantly, we observed that the effect of c646 on memory
consolidation and reconsolidation was temporally graded and dependent on the fear memory
being recalled; there was no effect of c646 infusion following delayed infusions or a noreactivation trial.
This is important given the fact that the IKK:NF-kB pathway interacts with the
p300/CBP HAT (Lubin & Sweatt, 2007). Specifically, IKK has been shown to directly interact
with p300/CBP to activate gene transcription through the acetylation of histones (Yamamoto et
al., 2003). Curcumin has been shown to be a modulator of both p300/CBP and IKK activity
(Balasubramanyam et al., 2004; Jobin et al., 1999), among a slew of other molecular events
(Gupta et al., 2012). One possible mechanism in which curcumin is impairing the consolidation
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and reconsolidation of a Pavlovian fear memory is through the interference with the IKKp300/CBP complex. Specifically, it may be the case that curcumin is impairing the activation of
IKK, which subsequently impairs the activation of p300/CBP, which leads to impaired fear
memory consolidation and reconsolidation.
This would make sense in light of our extinction findings. The p300/CBP HAT has been
shown to be critical for the extinction of a fear memory (Marek et al., 2011; Wei et al., 2012).
The retention of an extinction memory is dependent on the decrease of p300/CBP activity, i.e.
expression of p300/CBP decreases in the IL after fear memory extinction, and inhibition of
p300/CBP leads to an enhanced fear extinction. This might explain the paradoxical findings with
curcumin on fear memory extinction enhancement.
However, it is known that p300/CBP activity leads to the acetylation of histone H3
(Bedford & Brindle, 2012; Maddox et al., 2013; Zovkic & Sweatt, 2013). Our current extinction
findings show that, 90 minutes after a partial extinction protocol, curcumin has no effect on
histone H3 acetylation within the IL. This could be due to either a missed timepoint, as we know
there is a specific window of time in which the process of histone acetylation occurs (Maddox &
Schafe, 2011a; Monsey et al., 2011). Another possible explanation would be that the
IKK:p300/CBP complex may be affecting something else entirely within the IL.
Cohesively, the findings of the present dissertation are the first to systematically explore
the role of curcumin on the modulation of Pavlovian fear memories. We have demonstrated that
curcumin can impair the consolidation and reconsolidation, yet enhance the extinction, of an
auditory Pavlovian fear memory. Moreover, we have shown that curcumin has quite the opposite
effect on molecular events related to memory consolidation at the level of the infralimbic cortex
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compared to the lateral amygdala, yet curcumin’s effect on the IKK:NF-kB signaling pathway
remained the same.
Study Limitations
While the present dissertation examines the role of curcumin on Pavlovian fear memory
consolidation, reconsolidation, and extinction in light of the IKK:NF-kB inflammatory signaling
pathway, there many molecular pathways in which curcumin exerts its effects. Indeed, it has
been demonstrated that curcumin can be considered a “dirty bomb” due to its effects on a
multitude of molecular signaling pathways (Gupta et al., 2012). In relation to fear learning and
memory, curcumin has been shown to not only be a potent inhibitor of the IKK:NF-kB pathway,
but also of the p300/CBP histone acetyltransferase complex, the ERK and MAPK kinases, and
adrenergic receptors, to name a few. Further, all of these kinases and receptors interact with one
another in complex ways (Gupta et al., 2012), and it’s difficult to pinpoint the exact pathway
curcumin may be affecting. Further research is needed to elucidate the exact molecular cascade
in which curcumin exerts its effects.
Studies have shown that curcumin is a potent epigenetic regulator affecting a multitude of
epigenetic events, among them histone acetylation (Teiten, Dicato, & Diederich, 2013). While
our experiments demonstrate that curcumin regulates acetylation of histone H3 at the specific
lysine residue 18, we cannot conclusively say that curcumin is directly regulating the p300/CBP
HAT complex. Evidence indicates that the IKK:NF-kB signaling pathway, specifically IKK,
targets the p300/CBP complex and histones themselves, presenting further complications in
pinpointing the exact mechanism by which curcumin exerts its effects on auditory Pavlovian fear
memories.
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Whereas this dissertation examines the role of curcumin on Pavlovian fear memories,
there is a gap in the literature in relation to curcumin and other forms of memories, such as
spatial or recognition memories. Indeed, many of molecular pathways that are activated in the
lateral amygdala and infralimbic cortex during consolidation also occur in the hippocampus
(Levenson & Sweatt, 2005; Roth, Jnu, & Allis, 2001). Therefore, it would be problematic if
curcumin impaired spatial and recognition memories as well. However, given the effects of
curcumin on the extinction of a Pavlovian fear memory, it may well be that curcumin does not
have an effect on hippocampal based memories, or it may even enhance their consolidation
(Cheng et al., 2013; Issuriya, Kumarnsit, Wattanapiromsakul, & Vongvatcharanon, 2014; Pluta
et al., 2015). Few research studies have investigated the role, if any, of the IKK:NF-kB signaling
pathway on hippocampal based tasks. Recent studies have suggested that inflammation has
negative consequences on hippocampal based memories (Hein & O’Banion, 2009; Kohman &
Rhodes, 2013; Monje, Toda, & Palmer, 2003), suggesting that curcumin’s ability to limit
inflammatory signaling could be beneficial. Still, more research is needed to investigate
curcumin’s effect on hippocampal based memories.
Although our infusions experiments are informative of the systematic effects of curcumin
within specific brain regions, the delivery of curcumin through intracranial infusion is not an
available option for patients. What makes the scientific exploration of curcumin particularly
worthwhile is its status as a natural compound that is safe to consume in our normal diets.
However, it is known that dietary curcumin has poor bioavailability, and our dosage of curcumin
in our dietary studies far exceeds that which is normally prescribed for common psychiatric
prescriptions. Although safe to consume at even such a high dose, the ingestion of 60g of
curcumin per day for an adult is arduous. Further research is needed with both A) lower dosages
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of curcumin, and B) other curcumin analogs specifically formulated to have more bioavailability
at a lower dosage.
Future Directions
Recently, research has begun in exploring the effects of dietary curcumin on the
mammalian gut microbiome. Evidence suggests that curcumin has significant effects in changing
the microbiome in the rodent gut (Lim, 2016; Lopresti, Maes, Maker, Hood, & Drummond,
2014; Prasad et al., 2014; Sordillo & Helson, 2015; Yu, Pei, Zhang, Wen, & Yang, 2015),
leading to possible changes in immune function. This, combined with the recent evidence that
the gut microbiome has significant effects on brain functioning (Galland, 2014), leads to a
possible effect of curcumin on the microbiome, which subsequently affects brain functioning. A
possible line of research from the findings in this dissertation may focus on the effect of the gutbrain axis on trauma- and stressor-related disorders.
Further, other lines of research and recent advances in biochemistry have allowed for
increased bioavailability of curcumin (Boccia et al., 2007; Lubin & Sweatt, 2007; Si et al., 2012;
Yang et al., 2012). The first is evidence that curcumin combined with piperine increases
curcumin’s bioavailability by 154% in animals and by almost 2000% in humans (Anand et al.,
2007; Panahi, Badeli, Karami, & Sahebkar, 2015). A possible line of research from the findings
in this dissertation could be a focus on the modulation of Pavlovian fear memoires using
curcumin combined with piperine. This may lead to the use of a lower dose of curcumin, and
subsequently a potential option for clinical pharmacotherapy.
Second, novel biochemical products of curcumin have recently been developed in order
to increase their bioavailability (Prasad et al., 2014; Yang et al., 2013). Some are synthetic
analogs, such as EF-24 and EF-31, which aim to modify the curcumin molecule in order to
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increase its effectiveness in tissue. Other biochemical products, such as curcumin nanoparticles
(nanocurcumin), aim to increase curcumin’s solubility (Cheng et al., 2013; Issuriya, Kumarnsit,
Wattanapiromsakul, & Vongvatcharanon, 2014; Pluta et al., 2015). A possible line of research
from the findings in this dissertation may focus on using synthetic analogs of curcumin in
preclinical models of traumatic memory formation and modulation. This can lead to novel
findings in which an analog with increased bioavailability may be a suitable option as a
pharmacological therapeutic tool.
Finally, future studies should aim to translate the dietary work into research using human
participants. The behavioral experiments done in our previous dietary work (Monsey et al., 2015)
and in Chapter 4 could be replicated in human subjects to investigate the effects of curcumin on
fear memory consolidation, reconsolidation, and extinction processes.
Broader Implications
Psychiatric disorders that are characterized by intense fear and anxiety are becoming
increasingly widespread in today’s society. Therefore, it is of clinical importance to explore
novel treatment options that can have a high efficacy rate and minimal to no side effects.
Disorders such as PTSD have been typically treated with behavioral therapy and/or with
antidepressant medication. While both methods have had a considerable benefit for patients,
there are many undesirable side effects associated with each treatment option (Auxéméry, 2018;
Berger et al., 2009). Behavioral therapy forces patients to re-experience cues that trigger
traumatic experiences, and the chronic use of antidepressants results in numerous physiological
side effects. Given the need for better treatment options, this dissertation provides further
evidence for the use of curcumin, a naturally occurring compound, for those purposes.
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The results of Chapters 3 and 4, along with the results from Monsey et al. (2015) indicate
that curcumin can be used in both reconsolidation and extinction-based therapy for the treatment
of psychiatric disorders involving traumatic memories. A reconsolidation based therapeutic
approach is a more desirable option of treatment, as the patient is forced to reactivate their
trauma using a single presentation of a triggering cue. Further, many patients are subject to
reinstatement as a result of exposure to a stressful event, or the trauma may renew in a context
outside of the clinical setting. Evidence with curcumin suggests it may not only be effective in
conjunction with reconsolidation based behavioral therapy, but it may also prevent reinstatement
and renewal of the trauma. Further, as evidenced by the results in Chapter 4, curcumin may
facilitate extinction based behavioral therapy, and indeed prevent the trauma from reinstating or
renewing outside of the clinical setting.
Finally, much of the dissertation has focused on curcumin’s effect on the IKK:NF-kB
signaling pathway. Interestingly, impairing the activation of the IKK complex leads to
contrasting results in the lateral amygdala and the infralimbic cortex. In regard to the lateral
amygdala, impairment of IKK activation was associated with impaired histone acetylation and
subsequent immediate early gene activation after Pavlovian fear conditioning. However, within
the infralimbic cortex, impairment of the IKK complex was associated with increased activation
of immediate early genes after extinction training, suggesting enhanced consolidation of the
extinction memory (Figure 4.2). This is of clinical significance with regards to PTSD because
many patients report dysregulation of their immune system returning to homeostasis, thus having
a consistent immune response. Further, to our knowledge, this is the first systematic exploration
of the IKK:NF-kB inflammatory signaling pathway in regard to the extinction of a Pavlovian
fear memory in the rodent mammalian brain. Our studies indicate that the IKK:NF-kB signaling
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pathway is important in modulating fearful memories and may be a molecular signal important
for the brain to understand threat within its environment.
Overall Conclusions
The findings of the present dissertation clearly suggest a role for curcumin in modulating
the consolidation, reconsolidation, and extinction of a Pavlovian fear memory. Here, we
systematically explored the effects of curcumin on the lateral amygdala and infralimbic cortex,
two brain areas heavily implicated in the consolidation, reconsolidation, and extinction of
Pavlovian fear memories. Further, we have identified a common molecular link that ties two
seemingly opposing findings within two different brain regions, to result in the impairment of the
consolidation and reconsolidation of a Pavlovian fear memory, but also the enhancement of the
extinction of a Pavlovian fear memory. This dissertation therefore provides evidence for
curcumin to be a potential adjunctive therapy for patients who suffer from psychiatric disorders.
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